{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T00:18:29Z","timestamp":1793837909711,"version":"4.6.1"},"reference-count":243,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-026-06190-3","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T14:36:08Z","timestamp":1788964568000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["GPCR-Driven Muscarinic M1 and Histamine H1 Receptor Signaling Converging on the PI3K\/Akt\/mTOR Pathway: Functional Integration in Neuroinflammation and Myelin Repair in Multiple Sclerosis"],"prefix":"10.1007","volume":"63","author":[{"given":"Rohit Kumar","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janvi","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0034-835X","authenticated-orcid":false,"given":"Sidharth","family":"Mehan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divya","family":"Choudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuber","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajaram","family":"Samant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj","family":"Tongra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,9]]},"reference":[{"issue":"18","key":"6190_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/CELLS11182771","volume":"11","author":"T Kapoor","year":"2022","unstructured":"Kapoor T, Mehan S, Suri M, Sharma N, Kumar N, Narula AS et al (2022) Forskolin, an adenylcyclase\/cAMP\/CREB signaling activator restoring myelin-associated oligodendrocyte destruction in experimental ethidium bromide model of multiple sclerosis. Cells 11(18):2771. https:\/\/doi.org\/10.3390\/CELLS11182771","journal-title":"Cells"},{"key":"6190_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/JCM12134274","author":"Z Khan","year":"2023","unstructured":"Khan Z, Gupta GD, Mehan S (2023) Cellular and molecular evidence of multiple sclerosis diagnosis and treatment challenges. J Clin Med. https:\/\/doi.org\/10.3390\/JCM12134274","journal-title":"J Clin Med"},{"key":"6190_CR3","doi-asserted-by":"publisher","DOI":"10.1007\/S44197-025-00353-6","author":"G Khan","year":"2025","unstructured":"Khan G, Hashim MJ (2025) Epidemiology of multiple sclerosis: global, regional, national and sub-national-level estimates and future projections. J Epidemiol Glob Health. https:\/\/doi.org\/10.1007\/S44197-025-00353-6","journal-title":"J Epidemiol Glob Health"},{"key":"6190_CR4","unstructured":"Number of people with MS | Atlas of MS [Internet]. [cited 2026 Apr 11]. Available from: https:\/\/atlasofms.org\/map\/global\/epidemiology\/number-of-people-with-ms. Accessed\u00a026 Feb 2026"},{"key":"6190_CR5","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a028944","author":"L Alfredsson","year":"2019","unstructured":"Alfredsson L, Olsson T (2019) Lifestyle and environmental factors in multiple sclerosis. Cold Spring Harb Perspect Med. https:\/\/doi.org\/10.1101\/cshperspect.a028944","journal-title":"Cold Spring Harb Perspect Med"},{"key":"6190_CR6","doi-asserted-by":"publisher","unstructured":"Patsopoulos NA, Baranzini SE, Santaniello A, Shoostari P, Cotsapas C, Wong G et al (2019) Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility. Science 365(6460). https:\/\/doi.org\/10.1126\/SCIENCE.AAV7188","DOI":"10.1126\/SCIENCE.AAV7188"},{"key":"6190_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2016.187","author":"T Olsson","year":"2016","unstructured":"Olsson T, Barcellos LF, Alfredsson L, Nature Publishing Group (2016) Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis. Nat Rev Neurol. https:\/\/doi.org\/10.1038\/nrneurol.2016.187","journal-title":"Nat Rev Neurol"},{"issue":"9","key":"6190_CR8","doi-asserted-by":"publisher","first-page":"11718","DOI":"10.3390\/IJMS130911718","volume":"13","author":"C O\u2019Gorman","year":"2012","unstructured":"O\u2019Gorman C, Lucas R, Taylor B (2012) Environmental risk factors for multiple sclerosis: a review with a focus on molecular mechanisms. Int J Mol Sci 13(9):11718. https:\/\/doi.org\/10.3390\/IJMS130911718","journal-title":"Int J Mol Sci"},{"issue":"4","key":"6190_CR9","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.neuron.2018.01.021","volume":"97","author":"C Baecher-Allan","year":"2018","unstructured":"Baecher-Allan C, Kaskow BJ, Weiner HL (2018) Multiple sclerosis: mechanisms and immunotherapy. Neuron 97(4):742\u2013768. https:\/\/doi.org\/10.1016\/j.neuron.2018.01.021","journal-title":"Neuron"},{"issue":"Pt 10","key":"6190_CR10","doi-asserted-by":"publisher","first-page":"2904","DOI":"10.1093\/BRAIN\/AWS260","volume":"135","author":"H Lassmann","year":"2012","unstructured":"Lassmann H (2012) Cortical lesions in multiple sclerosis: inflammation versus neurodegeneration. Brain 135(Pt 10):2904\u20132905. https:\/\/doi.org\/10.1093\/BRAIN\/AWS260","journal-title":"Brain"},{"issue":"5","key":"6190_CR11","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1097\/NEN.0B013E3181A19A5A","volume":"68","author":"M Vercellino","year":"2009","unstructured":"Vercellino M, Masera S, Lorenzatti M, Condello C, Merola A, Mattioda A et al (2009) Demyelination, inflammation, and neurodegeneration in multiple sclerosis deep gray matter. J Neuropathol Exp Neurol 68(5):489\u2013502. https:\/\/doi.org\/10.1097\/NEN.0B013E3181A19A5A","journal-title":"J Neuropathol Exp Neurol"},{"issue":"2","key":"6190_CR12","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/J.NCL.2010.12.009","volume":"29","author":"GF Wu","year":"2011","unstructured":"Wu GF, Alvarez E (2011) The immunopathophysiology of multiple sclerosis. Neurol Clin 29(2):257\u2013278. https:\/\/doi.org\/10.1016\/J.NCL.2010.12.009","journal-title":"Neurol Clin"},{"issue":"1","key":"6190_CR13","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1159\/000548021","volume":"32","author":"KM Alem\u00e1n-Villa","year":"2025","unstructured":"Alem\u00e1n-Villa KM, Armienta-Rojas DA, Camberos-Barraza J, R\u00e1bago-Monz\u00f3n \u00c1R, Camacho-Zamora A, Osuna-Ramos JF et al (2025) Neuroinflammation across the spectrum of neurodegenerative diseases: mechanisms and therapeutic frontiers. NeuroImmunoModulation 32(1):278\u2013305. https:\/\/doi.org\/10.1159\/000548021","journal-title":"NeuroImmunoModulation"},{"key":"6190_CR14","unstructured":"Nourbakhsh B, Mowry EM (2019) Multiple sclerosis risk factors and pathogenesis [Internet]. Available from: http:\/\/journals.lww.com\/continuum.\u00a0Accessed 26 Feb 2026"},{"issue":"2","key":"6190_CR15","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2017","unstructured":"Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G et al (2017) Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 17(2):162\u2013173. https:\/\/doi.org\/10.1016\/S1474-4422(17)30470-2","journal-title":"Lancet Neurol"},{"key":"6190_CR16","doi-asserted-by":"publisher","unstructured":"Perrone V, Veronesi C, Giacomini E, Citraro R, Dell\u2019orco S, Lena F et al (2022) The epidemiology, treatment patterns and economic burden of different phenotypes of multiple sclerosis in Italy: relapsing-remitting multiple sclerosis and secondary progressive multiple sclerosis. Clin Epidemiol 14:1327. https:\/\/doi.org\/10.2147\/CLEP.S376005","DOI":"10.2147\/CLEP.S376005"},{"issue":"4","key":"6190_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/J.NEUROT.2025.E00601","volume":"22","author":"M Albelo-Mart\u00ednez","year":"2025","unstructured":"Albelo-Mart\u00ednez M, Rizvi S (2025) Progressive multiple sclerosis: evaluating current therapies and exploring future treatment strategies. Neurotherapeutics 22(4):e00601. https:\/\/doi.org\/10.1016\/J.NEUROT.2025.E00601","journal-title":"Neurotherapeutics"},{"issue":"3","key":"6190_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/NPR2.70039;PAGE:STRING:ARTICLE\/CHAPTER","volume":"45","author":"M Rajabi","year":"2025","unstructured":"Rajabi M, Shafaeibajestan S, Asadpour S, Alyari G, Taei N, Kohkalani M et al (2025) Primary progressive multiple sclerosis: new therapeutic approaches. Neuropsychopharmacol Rep 45(3):e70039. https:\/\/doi.org\/10.1002\/NPR2.70039;PAGE:STRING:ARTICLE\/CHAPTER","journal-title":"Neuropsychopharmacol Rep"},{"key":"6190_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/S13024-024-00742-8","author":"O Zveik","year":"2024","unstructured":"Zveik O, Rechtman A, Ganz T, Vaknin-Dembinsky A (2024) The interplay of inflammation and remyelination: rethinking MS treatment with a focus on oligodendrocyte progenitor cells. Mol Neurodegener. https:\/\/doi.org\/10.1186\/S13024-024-00742-8","journal-title":"Mol Neurodegener"},{"key":"6190_CR20","doi-asserted-by":"publisher","DOI":"10.7554\/ELIFE.18246","author":"F Mei","year":"2016","unstructured":"Mei F, Lehmann-Horn K, Shen YAA, Rankin KA, Stebbins KJ, Lorrain DS et al (2016) Accelerated remyelination during inflammatory demyelination prevents axonal loss and improves functional recovery. Elife. https:\/\/doi.org\/10.7554\/ELIFE.18246","journal-title":"Elife"},{"issue":"2","key":"6190_CR21","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1189\/JLB.0910486","volume":"89","author":"M Lapilla","year":"2011","unstructured":"Lapilla M, Gallo B, Martinello M, Procaccini C, Costanza M, Musio S et al (2011) Histamine regulates autoreactive T cell activation and adhesiveness in inflamed brain microcirculation. J Leukoc Biol 89(2):259\u2013267. https:\/\/doi.org\/10.1189\/JLB.0910486","journal-title":"J Leukoc Biol"},{"issue":"17","key":"6190_CR22","doi-asserted-by":"publisher","first-page":"3050","DOI":"10.1242\/DEV.137075","volume":"143","author":"JSL Yu","year":"2016","unstructured":"Yu JSL, Cui W (2016) Proliferation, survival and metabolism: the role of PI3K\/AKT\/mTOR signalling in pluripotency and cell fate determination. Development 143(17):3050\u20133060. https:\/\/doi.org\/10.1242\/DEV.137075","journal-title":"Development"},{"issue":"5","key":"6190_CR23","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1007\/S12640-021-00401-6","volume":"39","author":"A Singh","year":"2021","unstructured":"Singh A, Upadhayay S, Mehan S (2021) Understanding abnormal c-JNK\/p38MAPK signaling overactivation involved in the progression of multiple sclerosis: possible therapeutic targets and impact on neurodegenerative diseases. Neurotox Res 39(5):1630\u201350. https:\/\/doi.org\/10.1007\/S12640-021-00401-6","journal-title":"Neurotox Res"},{"key":"6190_CR24","doi-asserted-by":"publisher","unstructured":"Rasheed A, Khan G (2024) Epstein-Barr virus, vitamin D and the immune response: connections with consequences for multiple sclerosis. Front Immunol 15. https:\/\/doi.org\/10.3389\/FIMMU.2024.1503808","DOI":"10.3389\/FIMMU.2024.1503808"},{"issue":"5","key":"6190_CR25","doi-asserted-by":"publisher","first-page":"823","DOI":"10.2174\/1874467214666210301121432","volume":"14","author":"N Kumar","year":"2021","unstructured":"Kumar N, Sharma N, Mehan S (2021) Connection between JAK\/STAT and PPAR\u03b3 signaling during the progression of multiple sclerosis: insights into the modulation of T-cells and immune responses in the brain. Curr Mol Pharmacol 14(5):823\u201337. https:\/\/doi.org\/10.2174\/1874467214666210301121432","journal-title":"Curr Mol Pharmacol"},{"issue":"11","key":"6190_CR26","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1002\/GLIA.24602","volume":"72","author":"R Gao","year":"2024","unstructured":"Gao R, Song SJ, Tian MY, Wang LB, Zhang Y, Li X (2024) Myelin debris phagocytosis in demyelinating disease. Glia 72(11):1934\u20131954. https:\/\/doi.org\/10.1002\/GLIA.24602","journal-title":"Glia"},{"issue":"6","key":"6190_CR27","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/S1474-4422(21)00063-6","volume":"20","author":"A Bar-Or","year":"2021","unstructured":"Bar-Or A, Li R (2021) Cellular immunology of relapsing multiple sclerosis: interactions, checks, and balances. Lancet Neurol 20(6):470\u201383. https:\/\/doi.org\/10.1016\/S1474-4422(21)00063-6","journal-title":"Lancet Neurol"},{"key":"6190_CR28","doi-asserted-by":"publisher","unstructured":"Mohammed EMA (2016) Elucidating the molecular basis of multiple sclerosis and understanding the disease pathophysiology. Immunome Res 12(3). https:\/\/doi.org\/10.4172\/1745-7580.10000125","DOI":"10.4172\/1745-7580.10000125"},{"key":"6190_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/ADBI.202300073","author":"NS Alakhras","year":"2023","unstructured":"Alakhras NS, Kaplan MH (2023) Dendritic cells as a nexus for the development of multiple sclerosis and models of disease. Advanced Biology. https:\/\/doi.org\/10.1002\/ADBI.202300073","journal-title":"Advanced Biology"},{"issue":"19","key":"6190_CR30","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1146\/annurev-pathol-052920","volume":"2025","author":"SR Mur\u00faa","year":"2022","unstructured":"Mur\u00faa SR, Farez MF, Quintana FJ (2022) The immune response in multiple sclerosis. Annual Review of Pathology: Mechanisms of Disease Annu Rev Pathol Mech Dis 2025(19):121\u2013160. https:\/\/doi.org\/10.1146\/annurev-pathol-052920","journal-title":"Annu Rev Pathol Mech Dis"},{"issue":"6","key":"6190_CR31","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/S00281-019-00765-0","volume":"41","author":"F Ruiz","year":"2019","unstructured":"Ruiz F, Vigne S, Pot C (2019) Resolution of inflammation during multiple sclerosis. Semin Immunopathol 41(6):711\u2013726. https:\/\/doi.org\/10.1007\/S00281-019-00765-0","journal-title":"Semin Immunopathol"},{"key":"6190_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102647","author":"T Moser","year":"2020","unstructured":"Moser T, Akg\u00fcn K, Proschmann U, Sellner J, Ziemssen T (2020) The role of TH17 cells in multiple sclerosis: therapeutic implications. Autoimmun Rev. https:\/\/doi.org\/10.1016\/j.autrev.2020.102647","journal-title":"Autoimmun Rev"},{"key":"6190_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2021.107971","author":"E Colombo","year":"2022","unstructured":"Colombo E, Farina C (2022) Lessons from S1P receptor targeting in multiple sclerosis. Pharmacol Ther. https:\/\/doi.org\/10.1016\/j.pharmthera.2021.107971","journal-title":"Pharmacol Ther"},{"key":"6190_CR34","doi-asserted-by":"publisher","unstructured":"Baeyens A, Fang V, Chen C, Schwab SR (2015) Exit strategies: S1P signaling and T cell migration. Trends in Immunology. Elsevier Ltd 778\u201387. https:\/\/doi.org\/10.1016\/j.it.2015.10.005","DOI":"10.1016\/j.it.2015.10.005"},{"issue":"1","key":"6190_CR35","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/J.1600-065X.2006.00441.X","volume":"213","author":"MJ Carson","year":"2006","unstructured":"Carson MJ, Doose JM, Melchior B, Schmid CD, Ploix CC (2006) CNS immune privilege: hiding in plain sight. Immunol Rev 213(1):48\u201365. https:\/\/doi.org\/10.1111\/J.1600-065X.2006.00441.X","journal-title":"Immunol Rev"},{"key":"6190_CR36","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3389\/FIMMU.2022.996469","volume":"23","author":"R Liu","year":"2022","unstructured":"Liu R, Du S, Zhao L, Jain S, Sahay K, Rizvanov A et al (2022) Autoreactive lymphocytes in multiple sclerosis: pathogenesis and treatment target. Front Immunol 23:13. https:\/\/doi.org\/10.3389\/FIMMU.2022.996469","journal-title":"Front Immunol"},{"key":"6190_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2025.101947","author":"AM Afzali","year":"2025","unstructured":"Afzali AM, Korn T (2025) The role of the adaptive immune system in the initiation and persistence of multiple sclerosis. Semin Immunol. https:\/\/doi.org\/10.1016\/j.smim.2025.101947","journal-title":"Semin Immunol"},{"issue":"21","key":"6190_CR38","doi-asserted-by":"publisher","first-page":"10771","DOI":"10.3390\/IJMS262110771","volume":"26","author":"F Mailaender","year":"2025","unstructured":"Mailaender F, Vasilenko N, Tieck MP, Schembecker S, Kowarik MC (2025) The elusive B cell antigen in multiple sclerosis: time to rethink CNS B cell functions. Int J Mol Sci 26(21):10771. https:\/\/doi.org\/10.3390\/IJMS262110771","journal-title":"Int J Mol Sci"},{"issue":"7","key":"6190_CR39","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.3390\/CELLS10071605","volume":"10","author":"JJ Ahn","year":"2021","unstructured":"Ahn JJ, Abu-Rub M, Miller RH (2021) B Cells in neuroinflammation: new perspectives and mechanistic insights. Cells 10(7):1605. https:\/\/doi.org\/10.3390\/CELLS10071605","journal-title":"Cells"},{"issue":"7","key":"6190_CR40","doi-asserted-by":"publisher","first-page":"282","DOI":"10.21037\/ATM-21-3073","volume":"11","author":"H Jin","year":"2023","unstructured":"Jin H, Lu Q, Gao F, Hao H (2023) Application of oligoclonal bands and other cerebrospinal fluid variables in multiple sclerosis and other neuroimmunological diseases: a narrative review. Ann Transl Med 11(7):282\u2013282. https:\/\/doi.org\/10.21037\/ATM-21-3073","journal-title":"Ann Transl Med"},{"key":"6190_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/FIMMU.2021.676621","author":"AP Passaro","year":"2021","unstructured":"Passaro AP, Lebos AL, Yao Y, Stice SL (2021) Immune response in neurological pathology: emerging role of central and peripheral immune crosstalk. Front Immunol. https:\/\/doi.org\/10.3389\/FIMMU.2021.676621","journal-title":"Front Immunol"},{"issue":"2","key":"6190_CR42","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/S40828-022-00163-4","volume":"8","author":"U Lendeckel","year":"2022","unstructured":"Lendeckel U, Venz S, Wolke C (2022) Macrophages: shapes and functions. ChemTexts 8(2):12. https:\/\/doi.org\/10.1007\/S40828-022-00163-4","journal-title":"ChemTexts"},{"issue":"3","key":"6190_CR43","doi-asserted-by":"publisher","first-page":"27","DOI":"10.5493\/WJEM.V4.I3.27","volume":"4","author":"RA H\u00f8glund","year":"2014","unstructured":"H\u00f8glund RA, Maghazachi AA (2014) Multiple sclerosis and the role of immune cells. World J Exp Med 4(3):27. https:\/\/doi.org\/10.5493\/WJEM.V4.I3.27","journal-title":"World J Exp Med"},{"issue":"12","key":"6190_CR44","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/J.IT.2012.07.004","volume":"33","author":"B Engelhardt","year":"2012","unstructured":"Engelhardt B, Ransohoff RM (2012) Capture, crawl, cross: the T cell code to breach the blood-brain barriers. Trends Immunol 33(12):579\u2013589. https:\/\/doi.org\/10.1016\/J.IT.2012.07.004","journal-title":"Trends Immunol"},{"issue":"12","key":"6190_CR45","doi-asserted-by":"publisher","first-page":"4334","DOI":"10.1093\/BRAIN\/AWAC019","volume":"145","author":"H Nishihara","year":"2022","unstructured":"Nishihara H, Perriot S, Gastfriend BD, Steinfort M, Cibien C, Soldati S et al (2022) Intrinsic blood-brain barrier dysfunction contributes to multiple sclerosis pathogenesis. Brain 145(12):4334\u20134348. https:\/\/doi.org\/10.1093\/BRAIN\/AWAC019","journal-title":"Brain"},{"issue":"10","key":"6190_CR46","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/S41582-019-0240-Y","volume":"15","author":"PM Matthews","year":"2019","unstructured":"Matthews PM (2019) Chronic inflammation in multiple sclerosis\u2014seeing what was always there. Nat Rev Neurol 15(10):582\u2013593. https:\/\/doi.org\/10.1038\/S41582-019-0240-Y","journal-title":"Nat Rev Neurol"},{"key":"6190_CR47","doi-asserted-by":"publisher","unstructured":"Pyka-Fo\u015bciak G, Lis GJ, Litwin JA (2022) Adhesion molecule profile and the effect of anti-VLA-4 mAb treatment in experimental autoimmune encephalomyelitis, a mouse model of multiple sclerosis. Int J Mol Sci 23(9). https:\/\/doi.org\/10.3390\/IJMS23094637","DOI":"10.3390\/IJMS23094637"},{"issue":"9","key":"6190_CR48","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1177\/0271678X16655551","volume":"36","author":"RG Rempe","year":"2016","unstructured":"Rempe RG, Hartz AMS, Bauer B (2016) Matrix metalloproteinases in the brain and blood-brain barrier: Versatile breakers and makers. J Cereb Blood Flow Metab 36(9):1481\u20131507. https:\/\/doi.org\/10.1177\/0271678X16655551","journal-title":"J Cereb Blood Flow Metab"},{"key":"6190_CR49","doi-asserted-by":"publisher","unstructured":"Rodriguez\u2010mogeda C, Lorenzo SR, Attia J, Horssen J van, Witte ME, de Vries HE (2022) Breaching brain barriers: B cell migration in multiple sclerosis. Biomolecules 12(6). https:\/\/doi.org\/10.3390\/BIOM12060800","DOI":"10.3390\/BIOM12060800"},{"key":"6190_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/S12974-014-0201-8","author":"H Gonz\u00e1lez","year":"2014","unstructured":"Gonz\u00e1lez H, Pacheco R (2014) T-cell-mediated regulation of neuroinflammation involved in neurodegenerative diseases. J Neuroinflammation. https:\/\/doi.org\/10.1186\/S12974-014-0201-8","journal-title":"J Neuroinflammation"},{"issue":"1\u20132","key":"6190_CR51","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/J.JNS.2013.03.002","volume":"333","author":"A Rostami","year":"2013","unstructured":"Rostami A, Ciric B (2013) Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination. J Neurol Sci 333(1\u20132):76\u201387. https:\/\/doi.org\/10.1016\/J.JNS.2013.03.002","journal-title":"J Neurol Sci"},{"key":"6190_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117177","author":"NK Bhol","year":"2024","unstructured":"Bhol NK, Bhanjadeo MM, Singh AK, Dash UC, Ojha RR, Majhi S et al (2024) The interplay between cytokines, inflammation, and antioxidants: mechanistic insights and therapeutic potentials of various antioxidants and anti-cytokine compounds. Biomed Pharmacother. https:\/\/doi.org\/10.1016\/j.biopha.2024.117177","journal-title":"Biomed Pharmacother"},{"issue":"43","key":"6190_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/J.BBIH.2024.100928","volume":"1","author":"S Lai","year":"2024","unstructured":"Lai S, Wu X, Liu Y, Liu B, Wu H, Ma K (2024) Interaction between Th17 and central nervous system in multiple sclerosis. Brain Behav Immun Health 1(43):100928. https:\/\/doi.org\/10.1016\/J.BBIH.2024.100928","journal-title":"Brain Behav Immun Health"},{"key":"6190_CR54","doi-asserted-by":"publisher","unstructured":"Khan Z, Mehan S, Gupta G Das, Narula AS (2024) Immune system dysregulation in the progression of multiple sclerosis: molecular insights and therapeutic implications. Neuroscience. Elsevier Ltd 9\u201326. https:\/\/doi.org\/10.1016\/j.neuroscience.2024.04.004","DOI":"10.1016\/j.neuroscience.2024.04.004"},{"issue":"4","key":"6190_CR55","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/J.COPH.2009.04.008","volume":"9","author":"S Sanjabi","year":"2009","unstructured":"Sanjabi S, Zenewicz LA, Kamanaka M, Flavell RA (2009) Anti-inflammatory and pro-inflammatory roles of TGF-beta, IL-10, and IL-22 in immunity and autoimmunity. Curr Opin Pharmacol 9(4):447\u2013453. https:\/\/doi.org\/10.1016\/J.COPH.2009.04.008","journal-title":"Curr Opin Pharmacol"},{"issue":"2","key":"6190_CR56","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1189\/JLB.0412205","volume":"95","author":"J Jaczewska","year":"2014","unstructured":"Jaczewska J, Abdulreda MH, Yau CY, Schmitt MM, Schubert I, Berggren PO et al (2014) TNF-\u03b1 and IFN-\u03b3 promote lymphocyte adhesion to endothelial junctional regions facilitating transendothelial migration. J Leukoc Biol 95(2):265\u2013274. https:\/\/doi.org\/10.1189\/JLB.0412205","journal-title":"J Leukoc Biol"},{"key":"6190_CR57","doi-asserted-by":"publisher","unstructured":"Wojkowska DW, Szpakowski P, Glabinski A (2017) Interleukin 17A promotes lymphocytes adhesion and induces CCL2 and CXCL1 release from brain endothelial cells. Int J Mol Sci 18(5). https:\/\/doi.org\/10.3390\/IJMS18051000","DOI":"10.3390\/IJMS18051000"},{"key":"6190_CR58","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jtauto.2025.100313","volume":"1","author":"S Xu","year":"2025","unstructured":"Xu S, Thomas CJ, Nagaraja SS, Kumar R, Sawant K, Angappulige DH et al (2025) Redefining multiple sclerosis therapy through microbial immunomodulation and epigenetic control. J Transl Autoimmun 1:11. https:\/\/doi.org\/10.1016\/j.jtauto.2025.100313","journal-title":"J Transl Autoimmun"},{"key":"6190_CR59","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2023.1207007","author":"D Packer","year":"2023","unstructured":"Packer D, Fresenko EE, Harrington EP (2023) Remyelination in animal models of multiple sclerosis: finding the elusive grail of regeneration. Front Mol Neurosci. https:\/\/doi.org\/10.3389\/fnmol.2023.1207007. (Frontiers Media SA)","journal-title":"Front Mol Neurosci"},{"issue":"1","key":"6190_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/IJMS22010100","volume":"22","author":"W Ambrosius","year":"2020","unstructured":"Ambrosius W, Michalak S, Kozubski W, Kalinowska A (2020) Myelin oligodendrocyte glycoprotein antibody-associated disease: current insights into the disease pathophysiology, diagnosis and management. Int J Mol Sci 22(1):1\u201316. https:\/\/doi.org\/10.3390\/IJMS22010100","journal-title":"Int J Mol Sci"},{"issue":"9","key":"6190_CR61","doi-asserted-by":"publisher","first-page":"5875","DOI":"10.4049\/JIMMUNOL.175.9.5875","volume":"175","author":"N H\u00f6velmeyer","year":"2005","unstructured":"H\u00f6velmeyer N, Hao Z, Kranidioti K, Kassiotis G, Buch T, Frommer F et al (2005) Apoptosis of oligodendrocytes via Fas and TNF-R1 is a key event in the induction of experimental autoimmune encephalomyelitis. J Immunol 175(9):5875\u20135884. https:\/\/doi.org\/10.4049\/JIMMUNOL.175.9.5875","journal-title":"J Immunol"},{"issue":"4","key":"6190_CR62","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/NM.2324","volume":"17","author":"I Niki\u0107","year":"2011","unstructured":"Niki\u0107 I, Merkler D, Sorbara C, Brinkoetter M, Kreutzfeldt M, Bareyre FM et al (2011) A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis. Nat Med 17(4):495\u20139. https:\/\/doi.org\/10.1038\/NM.2324","journal-title":"Nat Med"},{"issue":"1","key":"6190_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pneurobio.2010.09.005","volume":"93","author":"R Dutta","year":"2011","unstructured":"Dutta R, Trapp BD (2011) Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis. Prog Neurobiol 93(1):1\u201312. https:\/\/doi.org\/10.1016\/j.pneurobio.2010.09.005","journal-title":"Prog Neurobiol"},{"issue":"Pt 7","key":"6190_CR64","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1093\/BRAIN\/AWR128","volume":"134","author":"L Haider","year":"2011","unstructured":"Haider L, Fischer MT, Frischer JM, Bauer J, H\u00f6ftberger R, Botond G et al (2011) Oxidative damage in multiple sclerosis lesions. Brain 134(Pt 7):1914\u20131924. https:\/\/doi.org\/10.1093\/BRAIN\/AWR128","journal-title":"Brain"},{"issue":"12","key":"6190_CR65","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1038\/NRN2023","volume":"7","author":"SG Waxman","year":"2006","unstructured":"Waxman SG (2006) Axonal conduction and injury in multiple sclerosis: the role of sodium channels. Nat Rev Neurosci 7(12):932\u2013941. https:\/\/doi.org\/10.1038\/NRN2023","journal-title":"Nat Rev Neurosci"},{"key":"6190_CR66","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/J.NBD.2013.08.010","volume":"60","author":"M Ma","year":"2013","unstructured":"Ma M (2013) Role of calpains in the injury-induced dysfunction and degeneration of the mammalian axon. Neurobiol Dis 60:61\u201379. https:\/\/doi.org\/10.1016\/J.NBD.2013.08.010","journal-title":"Neurobiol Dis"},{"issue":"49","key":"6190_CR67","doi-asserted-by":"publisher","first-page":"15397","DOI":"10.1523\/JNEUROSCI.4339-09.2009","volume":"29","author":"SG Meuth","year":"2009","unstructured":"Meuth SG, Herrmann AM, Simon OJ, Siffrin V, Melzer N, Bittner S et al (2009) Cytotoxic CD8+ T cell\u2013neuron interactions: perforin-dependent electrical silencing precedes but is not causally linked to neuronal cell death. J Neurosci 29(49):15397. https:\/\/doi.org\/10.1523\/JNEUROSCI.4339-09.2009","journal-title":"J Neurosci"},{"key":"6190_CR68","doi-asserted-by":"publisher","DOI":"10.3389\/FIMMU.2018.01029","author":"A Vural","year":"2018","unstructured":"Vural A, Doppler K, Meinl E (2018) Autoantibodies against the node of Ranvier in seropositive chronic inflammatory demyelinating polyneuropathy: diagnostic, pathogenic, and therapeutic relevance. Front Immunol. https:\/\/doi.org\/10.3389\/FIMMU.2018.01029","journal-title":"Front Immunol"},{"issue":"3\u20134","key":"6190_CR69","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1101\/GAD.344218.120","volume":"35","author":"LA Akay","year":"2021","unstructured":"Akay LA, Effenberger AH, Tsai LH (2021) Cell of all trades: oligodendrocyte precursor cells in synaptic, vascular, and immune function. Genes Dev 35(3\u20134):180\u201398. https:\/\/doi.org\/10.1101\/GAD.344218.120","journal-title":"Genes Dev"},{"key":"6190_CR70","doi-asserted-by":"publisher","unstructured":"Gao Z, Guo | Mengdi, Chen | Kehan, Jiang ML, Lin-Ming Zhang |, Di L et al (2025) Oligodendrocyte precursor cells in demyelination repair: mechanisms, crosstalk, and therapeutic frontiers. Medicine Bulletin. https:\/\/doi.org\/10.1002\/MDB2.70007","DOI":"10.1002\/MDB2.70007"},{"issue":"18","key":"6190_CR71","doi-asserted-by":"publisher","DOI":"10.3390\/CELLS14181408","volume":"14","author":"M Garc\u00eda-Dom\u00ednguez","year":"2025","unstructured":"Garc\u00eda-Dom\u00ednguez M (2025) White matter in crisis: oligodendrocytes and the pathophysiology of multiple sclerosis. Cells 14(18):1408. https:\/\/doi.org\/10.3390\/CELLS14181408","journal-title":"Cells"},{"issue":"14","key":"6190_CR72","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1177\/1352458519884006","volume":"25","author":"B Neumann","year":"2019","unstructured":"Neumann B, Segel M, Chalut KJ, Franklin RJM (2019) Remyelination and ageing: reversing the ravages of time. Mult Scler 25(14):1835. https:\/\/doi.org\/10.1177\/1352458519884006","journal-title":"Mult Scler"},{"issue":"21","key":"6190_CR73","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.3969\/J.ISSN.1673-5374.2013.21.009","volume":"8","author":"CY Guo","year":"2013","unstructured":"Guo CY, Sun L, Chen XP, Zhang DS (2013) Oxidative stress, mitochondrial damage and neurodegenerative diseases. Neural Regen Res 8(21):2003. https:\/\/doi.org\/10.3969\/J.ISSN.1673-5374.2013.21.009","journal-title":"Neural Regen Res"},{"key":"6190_CR74","doi-asserted-by":"publisher","DOI":"10.3390\/ANTIOX9080743","author":"DSA Simpson","year":"2020","unstructured":"Simpson DSA, Oliver PL (2020) ROS generation in microglia: understanding oxidative stress and inflammation in neurodegenerative disease. Antioxidants (Basel). https:\/\/doi.org\/10.3390\/ANTIOX9080743","journal-title":"Antioxidants (Basel)"},{"issue":"3","key":"6190_CR75","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s00415-004-0348-9","volume":"251","author":"Y Gilgun-Sherki","year":"2004","unstructured":"Gilgun-Sherki Y, Melamed E, Offen D (2004) The role of oxidative stress in the pathogenesis of multiple sclerosis: the need for effective antioxidant therapy. J Neurol 251(3):261\u2013268. https:\/\/doi.org\/10.1007\/s00415-004-0348-9","journal-title":"J Neurol"},{"key":"6190_CR76","doi-asserted-by":"publisher","DOI":"10.3389\/FNCEL.2021.681029","volume":"15","author":"J Subramanian","year":"2021","unstructured":"Subramanian J, Tremblay M\u00c8 (2021) Editorial: synaptic loss and neurodegeneration. Front Cell Neurosci 15:681029. https:\/\/doi.org\/10.3389\/FNCEL.2021.681029","journal-title":"Front Cell Neurosci"},{"key":"6190_CR77","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2023.1124333","author":"B Dean","year":"2023","unstructured":"Dean B, Bakker G, Ueda HR, Tobin AB, Brown A, Kanaan RAA (2023) A growing understanding of the role of muscarinic receptors in the molecular pathology and treatment of schizophrenia. Front Cell Neurosci. https:\/\/doi.org\/10.3389\/fncel.2023.1124333","journal-title":"Front Cell Neurosci"},{"key":"6190_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2017.09.011","author":"M Thomsen","year":"2018","unstructured":"Thomsen M, S\u00f8rensen G, Dencker D (2018) Physiological roles of CNS muscarinic receptors gained from knockout mice. Neuropharmacology. https:\/\/doi.org\/10.1016\/j.neuropharm.2017.09.011","journal-title":"Neuropharmacology"},{"key":"6190_CR79","doi-asserted-by":"publisher","unstructured":"Volpicelli LA, Levey AI (2004) Muscarinic acetylcholine receptor subtypes in cerebral cortex and hippocampus.Prog Brain Res. Elsevier 59\u201366. https:\/\/doi.org\/10.1016\/S0079-6123(03)45003-6","DOI":"10.1016\/S0079-6123(03)45003-6"},{"issue":"5","key":"6190_CR80","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1002\/dneu.20976","volume":"72","author":"F De Angelis","year":"2012","unstructured":"De Angelis F, Bernardo A, Magnaghi V, Minghetti L, Tata AM (2012) Muscarinic receptor subtypes as potential targets to modulate oligodendrocyte progenitor survival, proliferation, and differentiation. Dev Neurobiol 72(5):713\u2013728. https:\/\/doi.org\/10.1002\/dneu.20976","journal-title":"Dev Neurobiol"},{"key":"6190_CR81","doi-asserted-by":"publisher","DOI":"10.3390\/BIOMEDICINES8060153","author":"V Gatta","year":"2020","unstructured":"Gatta V, Mengod G, Reale M, Tata AM (2020) Possible correlation between cholinergic system alterations and neuro\/inflammation in multiple sclerosis. Biomedicines. https:\/\/doi.org\/10.3390\/BIOMEDICINES8060153","journal-title":"Biomedicines"},{"issue":"12","key":"6190_CR82","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.biopsych.2022.04.019","volume":"92","author":"WP Li","year":"2022","unstructured":"Li WP, Su XH, Hu NY, Hu J, Li XW, Yang JM et al (2022) Astrocytes mediate cholinergic regulation of adult hippocampal neurogenesis and memory through M1 muscarinic receptor. Biol Psychiatry 92(12):984\u2013998. https:\/\/doi.org\/10.1016\/j.biopsych.2022.04.019","journal-title":"Biol Psychiatry"},{"key":"6190_CR83","doi-asserted-by":"publisher","DOI":"10.3390\/ijms251910432","author":"K Wang","year":"2024","unstructured":"Wang K, Xie Y, Chen X, Ouyang X, Zhao L, Chen H et al (2024) The activation of muscarinic acetylcholine receptors protects against neuroinflammation in a mouse model through attenuating microglial inflammation. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms251910432","journal-title":"Int J Mol Sci"},{"key":"6190_CR84","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01085","author":"T Fujii","year":"2017","unstructured":"Fujii T, Mashimo M, Moriwaki Y, Misawa H, Ono S, Horiguchi K et al (2017) Expression and function of the cholinergic system in immune cells. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2017.01085","journal-title":"Front Immunol"},{"issue":"3","key":"6190_CR85","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1183\/09031936.00136710","volume":"39","author":"A Koarai","year":"2012","unstructured":"Koarai A, Traves SL, Fenwick PS, Brown SM, Chana KK, Russell REK et al (2012) Expression of muscarinic receptors by human macrophages. Eur Respir J 39(3):698\u2013704. https:\/\/doi.org\/10.1183\/09031936.00136710","journal-title":"Eur Respir J"},{"issue":"6","key":"6190_CR86","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1248\/BPB.B21-01005","volume":"45","author":"M Mashimo","year":"2022","unstructured":"Mashimo M, Kawashima K, Fujii T (2022) Non-neuronal cholinergic muscarinic acetylcholine receptors in the regulation of immune function. Biol Pharm Bull 45(6):675\u201383. https:\/\/doi.org\/10.1248\/BPB.B21-01005","journal-title":"Biol Pharm Bull"},{"key":"6190_CR87","doi-asserted-by":"publisher","unstructured":"Biddlecome GH, Berstein G, Ross EM (1996) Regulation of phospholipase C-beta1 by Gq and m1 muscarinic cholinergic receptor. Steady-state balance of receptor-mediated activation and GTPase-activating protein-promoted deactivation. J Biol Chem 271(14):7999\u20138007. https:\/\/doi.org\/10.1074\/JBC.271.14.7999","DOI":"10.1074\/JBC.271.14.7999"},{"issue":"5","key":"6190_CR88","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1085\/JGP.201210887","volume":"141","author":"BH Falkenburger","year":"2013","unstructured":"Falkenburger BH, Dickson EJ, Hille B (2013) Quantitative properties and receptor reserve of the DAG and PKC branch of G(q)-coupled receptor signaling. J Gen Physiol 141(5):537\u2013555. https:\/\/doi.org\/10.1085\/JGP.201210887","journal-title":"J Gen Physiol"},{"issue":"4","key":"6190_CR89","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s10571-019-00752-x","volume":"40","author":"MW Chen","year":"2020","unstructured":"Chen MW, Zhu H, Xiong CH, Li JB, Zhao LX, Chen HZ et al (2020) PKC and Ras are involved in M1 muscarinic receptor-mediated modulation of AMPA receptor GluA1 subunit. Cell Mol Neurobiol 40(4):547\u2013554. https:\/\/doi.org\/10.1007\/s10571-019-00752-x","journal-title":"Cell Mol Neurobiol"},{"issue":"5","key":"6190_CR90","doi-asserted-by":"publisher","first-page":"6622","DOI":"10.1096\/fj.201802351R","volume":"33","author":"LX Zhao","year":"2019","unstructured":"Zhao LX, Ge YH, Li JB, Xiong CH, Law PY, Xu JR et al (2019) M1 muscarinic receptors regulate the phosphorylation of AMPA receptor subunit GluA1 via a signaling pathway linking cAMP-PKA and PI3K-Akt. FASEB J 33(5):6622\u20136631. https:\/\/doi.org\/10.1096\/fj.201802351R","journal-title":"FASEB J"},{"key":"6190_CR91","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.606656","author":"ET van der Westhuizen","year":"2021","unstructured":"van der Westhuizen ET, Choy KHC, Valant C, McKenzie-Nickson S, Bradley SJ, Tobin AB et al (2021) Fine tuning muscarinic acetylcholine receptor signaling through allostery and bias. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2020.606656","journal-title":"Front Pharmacol"},{"key":"6190_CR92","doi-asserted-by":"publisher","DOI":"10.1016\/J.MOLPHA.2025.100027","author":"K Chen","year":"2025","unstructured":"Chen K, Park E, Abd-Elrahman KS (2025) Enhancing remyelination in multiple sclerosis via M1 muscarinic acetylcholine receptor. Mol Pharmacol. https:\/\/doi.org\/10.1016\/J.MOLPHA.2025.100027","journal-title":"Mol Pharmacol"},{"key":"6190_CR93","doi-asserted-by":"publisher","DOI":"10.3390\/IJMS20010213","author":"H Kawauchi","year":"2019","unstructured":"Kawauchi H, Yanai K, Wang DY, Itahashi K, Okubo K (2019) Antihistamines for allergic rhinitis treatment from the viewpoint of nonsedative properties. Int J Mol Sci. https:\/\/doi.org\/10.3390\/IJMS20010213","journal-title":"Int J Mol Sci"},{"issue":"180","key":"6190_CR94","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/B978-0-12-820107-7.00023-9","volume":"1","author":"P Panula","year":"2021","unstructured":"Panula P (2021) Histamine receptors, agonists, and antagonists in health and disease. Handb Clin Neurol 1(180):377\u2013387. https:\/\/doi.org\/10.1016\/B978-0-12-820107-7.00023-9","journal-title":"Handb Clin Neurol"},{"issue":"3","key":"6190_CR95","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1124\/pr.114.010249","volume":"67","author":"P Panula","year":"2015","unstructured":"Panula P, Chazot PL, Cowart M, Gutzmer R, Leurs R, Liu WLS et al (2015) International union of basic and clinical pharmacology.\u00a0XCVIII histamine receptors. Pharmacol Rev 67(3):601\u2013655. https:\/\/doi.org\/10.1124\/pr.114.010249","journal-title":"Pharmacol Rev"},{"issue":"2","key":"6190_CR96","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/0006-8993(90)91240-H","volume":"526","author":"MI Martinez-Mir","year":"1990","unstructured":"Martinez-Mir MI, Pollard H, Moreau J, Arrang JM, Ruat M, Traiffort E et al (1990) Three histamine receptors (H1, H2 and H3) visualized in the brain of human and non-human primates. Brain Res 526(2):322\u2013327. https:\/\/doi.org\/10.1016\/0006-8993(90)91240-H","journal-title":"Brain Res"},{"key":"6190_CR97","doi-asserted-by":"publisher","unstructured":"Li B, Zhu JN, Wang JJ (2014) Histaminergic afferent system in the cerebellum: structure and function. Cerebellum Ataxias 1(1). https:\/\/doi.org\/10.1186\/2053-8871-1-5","DOI":"10.1186\/2053-8871-1-5"},{"key":"6190_CR98","doi-asserted-by":"publisher","unstructured":"Parsons ME, Ganellin CR (2006) Histamine and its receptors. Br J Pharmacol 147 Suppl 1(Suppl 1). https:\/\/doi.org\/10.1038\/SJ.BJP.0706440","DOI":"10.1038\/SJ.BJP.0706440"},{"issue":"11","key":"6190_CR99","doi-asserted-by":"publisher","first-page":"3507","DOI":"10.1172\/JCI32792","volume":"117","author":"R Noubade","year":"2007","unstructured":"Noubade R, Milligan G, Zachary JF, Blankenhorn EP, Del Rio R, Rincon M et al (2007) Histamine receptor H1 is required for TCR-mediated p38 MAPK activation and optimal IFN-gamma production in mice. J Clin Invest 117(11):3507\u20133518. https:\/\/doi.org\/10.1172\/JCI32792","journal-title":"J Clin Invest"},{"key":"6190_CR100","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/9524075","author":"ACCC Branco","year":"2018","unstructured":"Branco ACCC, Yoshikawa FSY, Pietrobon AJ, Sato MN (2018) Role of histamine in modulating the immune response and inflammation. Mediators Inflamm. https:\/\/doi.org\/10.1155\/2018\/9524075","journal-title":"Mediators Inflamm"},{"key":"6190_CR101","doi-asserted-by":"publisher","unstructured":"Valesky EM, McKay S, Van Oosterhout AJM, Parnham MJ (2019) Anti-allergic drugs. Nijkamp and Parnham\u2019s Principles of Immunopharmacology: Fourth revised and extended edition 1:407\u2013423. https:\/\/doi.org\/10.1007\/978-3-030-10811-3_22","DOI":"10.1007\/978-3-030-10811-3_22"},{"issue":"2","key":"6190_CR102","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1007\/S11481-019-09887-6","volume":"15","author":"W Zhang","year":"2020","unstructured":"Zhang W, Zhang X, Zhang Y, Qu C, Zhou X, Zhang S (2020) Histamine induces microglia activation and the release of proinflammatory mediators in rat brain via H1R or H4R. J Neuroimmune Pharmacol 15(2):280\u2013291. https:\/\/doi.org\/10.1007\/S11481-019-09887-6","journal-title":"J Neuroimmune Pharmacol"},{"key":"6190_CR103","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-018-1068-x","author":"J Xu","year":"2018","unstructured":"Xu J, Zhang X, Qian Q, Wang Y, Dong H, Li N et al (2018) Histamine upregulates the expression of histamine receptors and increases the neuroprotective effect of astrocytes. J Neuroinflammation. https:\/\/doi.org\/10.1186\/s12974-018-1068-x","journal-title":"J Neuroinflammation"},{"key":"6190_CR104","doi-asserted-by":"publisher","unstructured":"Iida T, Yanai K, Yoshikawa T (2022) Histamine and microglia. In: Current Topics in Behavioral Neurosciences. Springer Science and Business Media Deutschland GmbH. 241\u201359. https:\/\/doi.org\/10.1007\/7854_2022_322","DOI":"10.1007\/7854_2022_322"},{"issue":"6","key":"6190_CR105","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/S0301-0082(00)00039-3","volume":"63","author":"RE Brown","year":"2001","unstructured":"Brown RE, Stevens DR, Haas HL (2001) The physiology of brain histamine. Prog Neurobiol 63(6):637\u2013672. https:\/\/doi.org\/10.1016\/S0301-0082(00)00039-3","journal-title":"Prog Neurobiol"},{"issue":"5","key":"6190_CR106","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1124\/MOL.60.5.1133","volume":"60","author":"RA Bakker","year":"2001","unstructured":"Bakker RA, Schoonus SBJ, Smit MJ, Timmerman H, Leurs R (2001) Histamine H(1)-receptor activation of nuclear factor-kappa B: roles for G beta gamma- and G alpha(q\/11)-subunits in constitutive and agonist-mediated signaling. Mol Pharmacol 60(5):1133\u20131142. https:\/\/doi.org\/10.1124\/MOL.60.5.1133","journal-title":"Mol Pharmacol"},{"issue":"1","key":"6190_CR107","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-31408-3","volume":"8","author":"D Kugelmann","year":"2018","unstructured":"Kugelmann D, Rotkopf LT, Radeva MY, Garcia-Ponce A, Walter E, Waschke J (2018) Histamine causes endothelial barrier disruption via Ca2+-mediated RhoA activation and tension at adherens junctions. Sci Rep 8(1):13229-. https:\/\/doi.org\/10.1038\/s41598-018-31408-3","journal-title":"Sci Rep"},{"issue":"6","key":"6190_CR108","doi-asserted-by":"publisher","first-page":"733","DOI":"10.2217\/FNL.12.72","volume":"7","author":"ZZ Chong","year":"2012","unstructured":"Chong ZZ, Shang YC, Wang S, Maiese K (2012) A critical kinase cascade in neurological disorders: PI 3-K, Akt, and mTOR. Future Neurol 7(6):733. https:\/\/doi.org\/10.2217\/FNL.12.72","journal-title":"Future Neurol"},{"key":"6190_CR109","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3389\/FPHAR.2022.1022053","volume":"24","author":"Q Wang","year":"2022","unstructured":"Wang Q, Shen ZN, Zhang SJ, Sun Y, Zheng FJ, Li YH (2022) Protective effects and mechanism of puerarin targeting PI3K\/Akt signal pathway on neurological diseases. Front Pharmacol 24:13. https:\/\/doi.org\/10.3389\/FPHAR.2022.1022053","journal-title":"Front Pharmacol"},{"issue":"11","key":"6190_CR110","doi-asserted-by":"publisher","first-page":"19700","DOI":"10.3390\/IJMS151119700","volume":"15","author":"F Cattaneo","year":"2014","unstructured":"Cattaneo F, Guerra G, Parisi M, De Marinis M, Tafuri D, Cinelli M et al (2014) Cell-surface receptors transactivation mediated by G protein-coupled receptors. Int J Mol Sci 15(11):19700\u201319728. https:\/\/doi.org\/10.3390\/IJMS151119700","journal-title":"Int J Mol Sci"},{"key":"6190_CR111","doi-asserted-by":"publisher","unstructured":"Weichhart T, S\u00e4emann MD (2008) The PI3K\/Akt\/mTOR pathway in innate immune cells: emerging therapeutic applications. Ann Rheum Dis. https:\/\/doi.org\/10.1136\/ard.2008.098459","DOI":"10.1136\/ard.2008.098459"},{"issue":"Pt 5","key":"6190_CR112","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1242\/JCS.093773","volume":"127","author":"S Jean","year":"2014","unstructured":"Jean S, Kiger AA (2014) Classes of phosphoinositide 3-kinases at a glance. J Cell Sci 127(Pt 5):923\u2013928. https:\/\/doi.org\/10.1242\/JCS.093773","journal-title":"J Cell Sci"},{"issue":"8","key":"6190_CR113","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/NRG1879","volume":"7","author":"JA Engelman","year":"2006","unstructured":"Engelman JA, Luo J, Cantley LC (2006) The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat Rev Genet 7(8):606\u2013619. https:\/\/doi.org\/10.1038\/NRG1879","journal-title":"Nat Rev Genet"},{"issue":"8","key":"6190_CR114","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/NRD2926","volume":"8","author":"P Liu","year":"2009","unstructured":"Liu P, Cheng H, Roberts TM, Zhao JJ (2009) Targeting the phosphoinositide 3-kinase (PI3K) pathway in cancer. Nat Rev Drug Discov 8(8):627. https:\/\/doi.org\/10.1038\/NRD2926","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"6190_CR115","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/NRC3860","volume":"15","author":"LM Thorpe","year":"2015","unstructured":"Thorpe LM, Yuzugullu H, Zhao JJ (2015) PI3K in cancer: divergent roles of isoforms, modes of activation and therapeutic targeting. Nat Rev Cancer 15(1):7\u201324. https:\/\/doi.org\/10.1038\/NRC3860","journal-title":"Nat Rev Cancer"},{"issue":"9","key":"6190_CR116","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/S41580-019-0129-Z","volume":"20","author":"B Bilanges","year":"2019","unstructured":"Bilanges B, Posor Y, Vanhaesebroeck B (2019) PI3K isoforms in cell signalling and vesicle trafficking. Nat Rev Mol Cell Biol 20(9):515\u2013534. https:\/\/doi.org\/10.1038\/S41580-019-0129-Z","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"3","key":"6190_CR117","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1042\/BJ20120008","volume":"443","author":"M Falasca","year":"2012","unstructured":"Falasca M, Maffucci T (2012) Regulation and cellular functions of class II phosphoinositide 3-kinases. Biochem J 443(3):587\u2013601. https:\/\/doi.org\/10.1042\/BJ20120008","journal-title":"Biochem J"},{"issue":"1","key":"6190_CR118","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/BJ20071427","volume":"410","author":"JM Backer","year":"2008","unstructured":"Backer JM (2008) The regulation and function of class III PI3Ks: novel roles for Vps34. Biochem J 410(1):1\u201317. https:\/\/doi.org\/10.1042\/BJ20071427","journal-title":"Biochem J"},{"issue":"6","key":"6190_CR119","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1083\/JCB.200907014","volume":"186","author":"A Simonsen","year":"2009","unstructured":"Simonsen A, Tooze SA (2009) Coordination of membrane events during autophagy by multiple class III PI3-kinase complexes. J Cell Biol 186(6):773\u2013782. https:\/\/doi.org\/10.1083\/JCB.200907014","journal-title":"J Cell Biol"},{"key":"6190_CR120","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19123725","author":"K S\u00e1nchez-Alegr\u00eda","year":"2018","unstructured":"S\u00e1nchez-Alegr\u00eda K, Flores-Le\u00f3n M, Avila-Mu\u00f1oz E, Rodr\u00edguez-Corona N, Arias C (2018) PI3K signaling in neurons: a central node for the control of multiple functions. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms19123725","journal-title":"Int J Mol Sci"},{"issue":"3","key":"6190_CR121","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/J.CELL.2017.04.001","volume":"169","author":"BD Manning","year":"2017","unstructured":"Manning BD, Toker A (2017) AKT\/PKB signaling: navigating the network. Cell 169(3):381\u2013405. https:\/\/doi.org\/10.1016\/J.CELL.2017.04.001","journal-title":"Cell"},{"issue":"5","key":"6190_CR122","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1128\/MCB.25.5.1869-1878.2005","volume":"25","author":"RM Easton","year":"2005","unstructured":"Easton RM, Cho H, Roovers K, Shineman DW, Mizrahi M, Forman MS et al (2005) Role for Akt3\/protein kinase B\u03b3 in attainment of normal brain size. Mol Cell Biol 25(5):1869. https:\/\/doi.org\/10.1128\/MCB.25.5.1869-1878.2005","journal-title":"Mol Cell Biol"},{"issue":"17","key":"6190_CR123","doi-asserted-by":"publisher","first-page":"E3940","DOI":"10.1073\/PNAS.1716109115\/-\/DCSUPPLEMENTAL","volume":"115","author":"I Lu\u010dic","year":"2018","unstructured":"Lu\u010dic I, Rathinaswamy MK, Truebestein L, Hamelin DJ, Burke JE, Leonard TA (2018) Conformational sampling of membranes by Akt controls its activation and inactivation. Proc Natl Acad Sci U S A 115(17):E3940\u2013E3949. https:\/\/doi.org\/10.1073\/PNAS.1716109115\/-\/DCSUPPLEMENTAL","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6190_CR124","doi-asserted-by":"publisher","DOI":"10.3390\/IJMS22136944","author":"M Ghomlaghi","year":"2021","unstructured":"Ghomlaghi M, Hart A, Hoang N, Shin S, Nguyen LK (2021) Feedback, crosstalk and competition: ingredients for emergent non-linear behaviour in the PI3K\/mTOR signalling network. Int J Mol Sci. https:\/\/doi.org\/10.3390\/IJMS22136944","journal-title":"Int J Mol Sci"},{"key":"6190_CR125","doi-asserted-by":"publisher","unstructured":"Martelli AM, Tabellini G, Bressanin D, Ognibene A, Goto K, Cocco L et al (2012) The emerging multiple roles of nuclear Akt. Biochim Biophys Acta 1823(12):2168\u20132178. https:\/\/doi.org\/10.1016\/J.BBAMCR.2012.08.017","DOI":"10.1016\/J.BBAMCR.2012.08.017"},{"issue":"6748","key":"6190_CR126","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/43466","volume":"401","author":"ON Ozes","year":"1999","unstructured":"Ozes ON, Mayo LD, Gustin JA, Pfeffer SR, Pfeffer LM, Donner DB (1999) NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature 401(6748):82\u201385. https:\/\/doi.org\/10.1038\/43466","journal-title":"Nature"},{"issue":"9","key":"6190_CR127","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/NCB839","volume":"4","author":"K Inoki","year":"2002","unstructured":"Inoki K, Li Y, Zhu T, Wu J, Guan KL (2002) TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat Cell Biol 4(9):648\u2013657. https:\/\/doi.org\/10.1038\/NCB839","journal-title":"Nat Cell Biol"},{"issue":"6","key":"6190_CR128","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/J.TIBS.2011.03.006","volume":"36","author":"MC Mendoza","year":"2011","unstructured":"Mendoza MC, Er EE, Blenis J (2011) The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation. Trends Biochem Sci 36(6):320\u2013328. https:\/\/doi.org\/10.1016\/J.TIBS.2011.03.006","journal-title":"Trends Biochem Sci"},{"key":"6190_CR129","doi-asserted-by":"publisher","DOI":"10.1016\/j.soc.2013.06.008","author":"B Hassan","year":"2013","unstructured":"Hassan B, Akcakanat A, Holder AM, Meric-Bernstam F (2013) Targeting the PI3-kinase\/Akt\/mTOR signaling pathway. Surg Oncol Clin N Am. https:\/\/doi.org\/10.1016\/j.soc.2013.06.008","journal-title":"Surg Oncol Clin N Am"},{"issue":"4","key":"6190_CR130","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/S41580-019-0199-Y","volume":"21","author":"GY Liu","year":"2020","unstructured":"Liu GY, Sabatini DM (2020) mTOR at the nexus of nutrition, growth, ageing and disease. Nat Rev Mol Cell Biol 21(4):183\u2013203. https:\/\/doi.org\/10.1038\/S41580-019-0199-Y","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"3","key":"6190_CR131","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/NRM3757","volume":"15","author":"M Shimobayashi","year":"2014","unstructured":"Shimobayashi M, Hall MN (2014) Making new contacts: the mTOR network in metabolism and signalling crosstalk. Nat Rev Mol Cell Biol 15(3):155\u2013162. https:\/\/doi.org\/10.1038\/NRM3757","journal-title":"Nat Rev Mol Cell Biol"},{"key":"6190_CR132","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.02.004","author":"RA Saxton","year":"2017","unstructured":"Saxton RA, Sabatini DM (2017) mTOR signaling in growth, metabolism, and disease. Cell. https:\/\/doi.org\/10.1016\/j.cell.2017.02.004","journal-title":"Cell"},{"issue":"5","key":"6190_CR133","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/NRM2672","volume":"10","author":"XM Ma","year":"2009","unstructured":"Ma XM, Blenis J (2009) Molecular mechanisms of mTOR-mediated translational control. Nat Rev Mol Cell Biol 10(5):307\u2013318. https:\/\/doi.org\/10.1038\/NRM2672","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1\u20132","key":"6190_CR134","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/S11010-011-1110-0","volume":"361","author":"Z Zhang","year":"2012","unstructured":"Zhang Z, Zhang G, Xu X, Su W, Yu B (2012) mTOR-rictor is the Ser473 kinase for AKT1 in mouse one-cell stage embryos. Mol Cell Biochem 361(1\u20132):249\u2013257. https:\/\/doi.org\/10.1007\/S11010-011-1110-0","journal-title":"Mol Cell Biochem"},{"issue":"12","key":"6190_CR135","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/S41580-023-00641-8","volume":"24","author":"C Goul","year":"2023","unstructured":"Goul C, Peruzzo R, Zoncu R (2023) The molecular basis of nutrient sensing and signalling by mTORC1 in metabolism regulation and disease. Nat Rev Mol Cell Biol 24(12):857\u2013875. https:\/\/doi.org\/10.1038\/S41580-023-00641-8","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6","key":"6190_CR136","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/S00401-013-1112-Y","volume":"125","author":"A Boyd","year":"2013","unstructured":"Boyd A, Zhang H, Williams A (2013) Insufficient OPC migration into demyelinated lesions is a cause of poor remyelination in MS and mouse models. Acta Neuropathol 125(6):841. https:\/\/doi.org\/10.1007\/S00401-013-1112-Y","journal-title":"Acta Neuropathol"},{"key":"6190_CR137","doi-asserted-by":"publisher","unstructured":"Poon MM, Lorrain KI, Stebbins KJ, Edu GC, Broadhead AR, Lorenzana AJ et al (2024) Targeting the muscarinic M1 receptor with a selective, brain-penetrant antagonist to promote remyelination in multiple sclerosis. Proc Natl Acad Sci USA 121(32). https:\/\/doi.org\/10.1073\/pnas.2407974121","DOI":"10.1073\/pnas.2407974121"},{"issue":"10111","key":"6190_CR138","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1016\/S0140-6736(17)32346-2","volume":"390","author":"AJ Green","year":"2017","unstructured":"Green AJ, Gelfand JM, Cree BA, Bevan C, Boscardin WJ, Mei F et al (2017) Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial. The Lancet 390(10111):2481\u20132489. https:\/\/doi.org\/10.1016\/S0140-6736(17)32346-2","journal-title":"The Lancet"},{"key":"6190_CR139","doi-asserted-by":"publisher","unstructured":"Kocot J, Kosa P, Ashida S, Pirjanian NA, Goldbach-Mansky R, Peterson K et al (2025) Clemastine fumarate accelerates accumulation of disability in progressive multiple sclerosis by enhancing pyroptosis. J Clin Investig 135(10). https:\/\/doi.org\/10.1172\/JCI183941","DOI":"10.1172\/JCI183941"},{"key":"6190_CR140","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2025.1582902","volume":"19","author":"R Yamazaki","year":"2025","unstructured":"Yamazaki R, Ohno N (2025) The potential of repurposing clemastine to promote remyelination. Front Cell Neurosci 19:1582902. https:\/\/doi.org\/10.3389\/fncel.2025.1582902","journal-title":"Front Cell Neurosci"},{"key":"6190_CR141","doi-asserted-by":"publisher","unstructured":"Kamen Y, Evans KA, Sitnikov S, Spitzer SO, de Faria O, Yucel M et al (2024) Clemastine and metformin extend the window of NMDA receptor surface expression in ageing oligodendrocyte precursor cells. Sci Rep 14(1). https:\/\/doi.org\/10.1038\/s41598-024-53615-x","DOI":"10.1038\/s41598-024-53615-x"},{"key":"6190_CR142","doi-asserted-by":"publisher","DOI":"10.1038\/S41598-022-10095-1","author":"RA Seidman","year":"2022","unstructured":"Seidman RA, Khattab H, Polanco JJ, Broome JE, Sim FJ (2022) Oscillatory calcium release and sustained store-operated oscillatory calcium signaling prevents differentiation of human oligodendrocyte progenitor cells. Sci Rep. https:\/\/doi.org\/10.1038\/S41598-022-10095-1","journal-title":"Sci Rep"},{"issue":"7471","key":"6190_CR143","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/NATURE12647","volume":"502","author":"VA Deshmukh","year":"2013","unstructured":"Deshmukh VA, Tardif V, Lyssiotis CA, Green CC, Kerman B, Kim HJ et al (2013) A regenerative approach to the treatment of multiple sclerosis. Nature 502(7471):327\u2013332. https:\/\/doi.org\/10.1038\/NATURE12647","journal-title":"Nature"},{"issue":"5","key":"6190_CR144","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s12264-015-1555-3","volume":"31","author":"Z Li","year":"2015","unstructured":"Li Z, He Y, Fan S, Sun B (2015) Clemastine rescues behavioral changes and enhances remyelination in the cuprizone mouse model of demyelination. Neurosci Bull 31(5):617\u2013625. https:\/\/doi.org\/10.1007\/s12264-015-1555-3","journal-title":"Neurosci Bull"},{"issue":"1","key":"6190_CR145","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1021\/acsmedchemlett.0c00626","volume":"12","author":"TO Schrader","year":"2021","unstructured":"Schrader TO, Xiong Y, Lorenzana AO, Broadhead A, Stebbins KJ, Poon MM et al (2021) Discovery of PIPE-359, a brain-penetrant, selective m1receptor antagonist with robust efficacy in murine MOG-EAE. ACS Med Chem Lett 12(1):155\u2013161. https:\/\/doi.org\/10.1021\/acsmedchemlett.0c00626","journal-title":"ACS Med Chem Lett"},{"key":"6190_CR146","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.intimp.2023.111481","volume":"15","author":"SM Ibrahim","year":"2024","unstructured":"Ibrahim SM, Kamel AS, Ahmed KA, Mohammed RA, Essam RM (2024) The preferential effect of Clemastine on F3\/Contactin-1\/Notch-1 compared to Jagged-1\/Notch-1 justifies its remyelinating effect in an experimental model of multiple sclerosis in rats. Int Immunopharmacol 15:128. https:\/\/doi.org\/10.1016\/j.intimp.2023.111481","journal-title":"Int Immunopharmacol"},{"key":"6190_CR147","unstructured":"Study Details | NCT06083753 | Study to evaluate the safety and efficacy of PIPE-307 in subjects with relapsing-remitting multiple sclerosis | ClinicalTrials.gov [Internet]. [cited 2026 Jan 5]. Available from: \nhttps:\/\/clinicaltrials.gov\/study\/NCT06083753.\u00a0Accessed 26 Feb 2026"},{"key":"6190_CR148","doi-asserted-by":"crossref","unstructured":"Lock C, Hermans G, Pedotti R, Brendolan A, Schadt E, Garren H et al (2002) Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. NATURE MEDICINE \u2022 [Internet]. Available from: http:\/\/medicine.nature.com.\u00a0Accessed 26 Feb 2026","DOI":"10.1038\/nm0502-500"},{"key":"6190_CR149","doi-asserted-by":"publisher","DOI":"10.1186\/2045-8118-10-19","author":"U Kallweit","year":"2013","unstructured":"Kallweit U, Aritake K, Bassetti CL, Blumenthal S, Hayaishi O, Linnebank M et al (2013) Elevated CSF histamine levels in multiple sclerosis patients. Fluids Barriers CNS. https:\/\/doi.org\/10.1186\/2045-8118-10-19","journal-title":"Fluids Barriers CNS"},{"issue":"1\u20132","key":"6190_CR150","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.jneuroim.2014.09.018","volume":"277","author":"M Costanza","year":"2014","unstructured":"Costanza M, Di Dario M, Steinman L, Farina C, Pedotti R (2014) Gene expression analysis of histamine receptors in peripheral blood mononuclear cells from individuals with clinically-isolated syndrome and different stages of multiple sclerosis. J Neuroimmunol 277(1\u20132):186\u2013188. https:\/\/doi.org\/10.1016\/j.jneuroim.2014.09.018","journal-title":"J Neuroimmunol"},{"issue":"4","key":"6190_CR151","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1177\/039463200501800421","volume":"18","author":"L Logothetis","year":"2005","unstructured":"Logothetis L, Mylonas IA, Baloyannis S, Pashalidou M, Orologas A, Zafeiropoulos A et al (2005) A pilot, open label, clinical trial using hydroxyzine in multiple sclerosis. Int J Immunopathol Pharmacol 18(4):771\u2013778. https:\/\/doi.org\/10.1177\/039463200501800421","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"2","key":"6190_CR152","doi-asserted-by":"publisher","first-page":"583","DOI":"10.3233\/JAD-151146","volume":"53","author":"AV Ivachtchenko","year":"2016","unstructured":"Ivachtchenko AV, Lavrovsky Y, Okun I (2016) AVN-101: a multi-target drug candidate for the treatment of CNS disorders. J Alzheimer\u2019s Dis 53(2):583. https:\/\/doi.org\/10.3233\/JAD-151146","journal-title":"J Alzheimer\u2019s Dis"},{"key":"6190_CR153","doi-asserted-by":"publisher","unstructured":"Alonso A, Jick SS, Hern\u00e1n MA (2006) Allergy, histamine 1 receptor blockers, and the risk of multiple sclerosis. Neurology 66(4):572\u2013575.https:\/\/doi.org\/10.1212\/01.wnl.0000198507.13597.45","DOI":"10.1212\/01.wnl.0000198507.13597.45"},{"issue":"6","key":"6190_CR154","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1002\/EJI.201141859","volume":"42","author":"N Saligrama","year":"2012","unstructured":"Saligrama N, Noubade R, Case LK, del Rio R, Teuscher C (2012) Combinatorial roles for histamine H 1-H 2 and H 3-H 4 receptors in autoimmune inflammatory disease of the central nervous system. Eur J Immunol 42(6):1536\u20131546. https:\/\/doi.org\/10.1002\/EJI.201141859","journal-title":"Eur J Immunol"},{"issue":"9","key":"6190_CR155","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/S0192-0561(00)00029-1","volume":"22","author":"V Dimitriadou","year":"2000","unstructured":"Dimitriadou V, Pang X, Theoharides TC (2000) Hydroxyzine inhibits experimental allergic encephalomyelitis (EAE) and associated brain mast cell activation. Int J Immunopharmacol 22(9):673\u2013684. https:\/\/doi.org\/10.1016\/S0192-0561(00)00029-1","journal-title":"Int J Immunopharmacol"},{"key":"6190_CR156","doi-asserted-by":"publisher","unstructured":"Pedotti R, DeVoss JJ, Youssef S, Mitchell D, Wedemeyer J, Madanat R, Garren H, Fontoura P, Tsai M, Galli SJ, Sobel RA, Steinman L (2003) Multiple elements of the allergic arm of the immune response modulate autoimmune demyelination. Proceedings of the National Academy of Sciences of the United States of America 100(4):1867\u20131872. https:\/\/doi.org\/10.1073\/pnas.252777399","DOI":"10.1073\/pnas.252777399"},{"issue":"3","key":"6190_CR157","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1006\/mvre.2001.2350","volume":"62","author":"AS Easton","year":"2001","unstructured":"Easton AS, Dorovini-Zis K (2001) The kinetics, function, and regulation of P-selectin expressed by human brain microvessel endothelial cells in primary culture. Microvasc Res 62(3):335\u2013345. https:\/\/doi.org\/10.1006\/mvre.2001.2350","journal-title":"Microvasc Res"},{"issue":"2","key":"6190_CR158","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1006\/cimm.1996.0205","volume":"171","author":"I Miki","year":"1996","unstructured":"Miki I, Kusano A, Ohta S, Hanai N, Otoshi M, Masaki S et al (1996) Histamine enhanced the TNF-\u03b1-induced expression of E-selectin and ICAM-1 on vascular endothelial cells. Cell Immunol 171(2):285\u2013288. https:\/\/doi.org\/10.1006\/cimm.1996.0205","journal-title":"Cell Immunol"},{"issue":"44","key":"6190_CR159","doi-asserted-by":"publisher","first-page":"18967","DOI":"10.1073\/pnas.1008816107","volume":"107","author":"C Lu","year":"2010","unstructured":"Lu C, Diehl SA, Noubade R, Ledoux J, Nelson MT, Spach K et al (2010) Endothelial histamine H1 receptor signaling reduces blood-brain barrier permeability and susceptibility to autoimmune encephalomyelitis. Proc Natl Acad Sci USA 107(44):18967\u201318972. https:\/\/doi.org\/10.1073\/pnas.1008816107","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"6190_CR160","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1007\/s12035-014-8697-6","volume":"49","author":"H Dong","year":"2014","unstructured":"Dong H, Zhang W, Zeng X, Hu G, Zhang H, He S et al (2014) Histamine induces upregulated expression of histamine receptors and increases release of inflammatory mediators from microglia. Mol Neurobiol 49(3):1487\u20131500. https:\/\/doi.org\/10.1007\/s12035-014-8697-6","journal-title":"Mol Neurobiol"},{"key":"6190_CR161","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.bbr.2024.114964","volume":"8","author":"Z Zhou","year":"2024","unstructured":"Zhou Z, An Q, Zhang W, Li Y, Zhang Q, Yan H (2024) Histamine and receptors in neuroinflammation: their roles on neurodegenerative diseases. Behav Brain Res 8:465. https:\/\/doi.org\/10.1016\/j.bbr.2024.114964","journal-title":"Behav Brain Res"},{"issue":"11","key":"6190_CR162","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.2174\/1570159X22666240319123151","volume":"22","author":"B Tighilet","year":"2024","unstructured":"Tighilet B, Trico J, Marouane E, Zwergal A, Chabbert C (2024) Histaminergic system and vestibular function in normal and pathological conditions. Curr Neuropharmacol 22(11):1826. https:\/\/doi.org\/10.2174\/1570159X22666240319123151","journal-title":"Curr Neuropharmacol"},{"issue":"1\u20132","key":"6190_CR163","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/0006-8993(88)91554-5","volume":"450","author":"L Arbon\u00e9s","year":"1988","unstructured":"Arbon\u00e9s L, Picatoste F, Garc\u00eda A (1988) Histamine H1-receptors mediate phosphoinositide hydrolysis in astrocyte-enriched primary cultures. Brain Res 450(1\u20132):144\u2013152. https:\/\/doi.org\/10.1016\/0006-8993(88)91554-5","journal-title":"Brain Res"},{"issue":"6","key":"6190_CR164","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/S00011-004-1247-3\/METRICS","volume":"53","author":"M Lipnik-\u0160tangelj","year":"2004","unstructured":"Lipnik-\u0160tangelj M, \u010carman-Kr\u017ean M (2004) Activation of histamine H1-receptor enhances neurotrophic factor secretion from cultured astrocytes. Inflamm Res 53(6):245\u2013252. https:\/\/doi.org\/10.1007\/S00011-004-1247-3\/METRICS","journal-title":"Inflamm Res"},{"issue":"5581","key":"6190_CR165","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1126\/SCIENCE.1072810","volume":"297","author":"RZ Ma","year":"2002","unstructured":"Ma RZ, Gao J, Meeker ND, Fillmore PD, Tung KSK, Watanabe T et al (2002) Identification of Bphs, an autoimmune disease locus, as histamine receptor H1. Science 297(5581):620\u2013623. https:\/\/doi.org\/10.1126\/SCIENCE.1072810","journal-title":"Science"},{"key":"6190_CR166","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23116347","author":"S Amadio","year":"2022","unstructured":"Amadio S, Conte F, Esposito G, Fiscon G, Paci P, Volont\u00e9 C (2022) Repurposing histaminergic drugs in multiple sclerosis. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23116347","journal-title":"Int J Mol Sci"},{"issue":"8","key":"6190_CR167","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.15252\/EMBR.201541905","volume":"17","author":"A Kitz","year":"2016","unstructured":"Kitz A, de Marcken M, Gautron A, Mitrovic M, Hafler DA, Dominguez-Villar M (2016) AKT isoforms modulate Th1-like Treg generation and function in human autoimmune disease. EMBO Rep 17(8):1169\u20131183. https:\/\/doi.org\/10.15252\/EMBR.201541905","journal-title":"EMBO Rep"},{"key":"6190_CR168","doi-asserted-by":"publisher","DOI":"10.3390\/CELLS14181445","author":"J Schl\u00f6der","year":"2025","unstructured":"Schl\u00f6der J, Trinschek B, Luessi F, Jonuleit H (2025) Impaired PTEN expression in T cells drives resistance to treg-mediated immune regulation in multiple sclerosis. Cells. https:\/\/doi.org\/10.3390\/CELLS14181445","journal-title":"Cells"},{"issue":"2","key":"6190_CR169","doi-asserted-by":"publisher","first-page":"141","DOI":"10.22034\/IJI.2016.16665","volume":"13","author":"M Salehi","year":"2016","unstructured":"Salehi M, Bagherpour B, Shayghannejad V, Mohebi F, Jafari R (2016) Th1, Th2 and Th17 cytokine profile in patients with multiple sclerosis following treatment with rapamycin. Iran J Immunol 13(2):141\u2013147. https:\/\/doi.org\/10.22034\/IJI.2016.16665","journal-title":"Iran J Immunol"},{"issue":"26","key":"6190_CR170","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/J.MSARD.2018.08.009","volume":"1","author":"B Bagherpour","year":"2018","unstructured":"Bagherpour B, Salehi M, Jafari R, Bagheri A, Kiani-Esfahani A, Edalati M et al (2018) Promising effect of rapamycin on multiple sclerosis. Mult Scler Relat Disord 1(26):40\u201345. https:\/\/doi.org\/10.1016\/J.MSARD.2018.08.009","journal-title":"Mult Scler Relat Disord"},{"issue":"5","key":"6190_CR171","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1002\/ANA.21958","volume":"67","author":"B Moraal","year":"2010","unstructured":"Moraal B, van den Elskamp IJ, Knol DL, Uitdehaag BMJ, Geurts JJG, Vrenken H et al (2010) Long-interval T2-weighted subtraction magnetic resonance imaging: a powerful new outcome measure in multiple sclerosis trials. Ann Neurol 67(5):667\u2013675. https:\/\/doi.org\/10.1002\/ANA.21958","journal-title":"Ann Neurol"},{"issue":"5","key":"6190_CR172","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1001\/JAMANEUROL.2015.4807","volume":"73","author":"L Negrotto","year":"2016","unstructured":"Negrotto L, Farez MF, Correale J (2016) Immunologic effects of metformin and pioglitazone treatment on metabolic syndrome and multiple sclerosis. JAMA Neurol 73(5):520\u2013528. https:\/\/doi.org\/10.1001\/JAMANEUROL.2015.4807","journal-title":"JAMA Neurol"},{"issue":"10","key":"6190_CR173","doi-asserted-by":"publisher","first-page":"2831","DOI":"10.1007\/S11064-017-2296-7","volume":"42","author":"H Hou","year":"2017","unstructured":"Hou H, Miao J, Cao R, Han M, Sun Y, Liu X et al (2017) Rapamycin ameliorates experimental autoimmune encephalomyelitis by suppressing the mTOR-STAT3 pathway. Neurochem Res 42(10):2831\u20132840. https:\/\/doi.org\/10.1007\/S11064-017-2296-7","journal-title":"Neurochem Res"},{"issue":"1","key":"6190_CR174","doi-asserted-by":"publisher","first-page":"78","DOI":"10.4049\/jimmunol.2000043","volume":"205","author":"AK Stark","year":"2020","unstructured":"Stark AK, Davenport ECM, Patton DT, Scudamore CL, Vanhaesebroeck B, Veldhoen M et al (2020) Loss of phosphatidylinositol 3-kinase activity in regulatory T cells leads to neuronal inflammation. J Immunol 205(1):78\u201389. https:\/\/doi.org\/10.4049\/jimmunol.2000043","journal-title":"J Immunol"},{"issue":"3","key":"6190_CR175","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1111\/imm.12789","volume":"152","author":"NA Nadya","year":"2017","unstructured":"Nadya NA, Tezuka H, Ohteki T, Matsuda S, Azuma M, Nagai S (2017) PI3K-Akt pathway enhances the differentiation of interleukin-27-induced type 1 regulatory T cells. Immunology 152(3):507\u2013516. https:\/\/doi.org\/10.1111\/imm.12789","journal-title":"Immunology"},{"issue":"5","key":"6190_CR176","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.4049\/jimmunol.1701204","volume":"202","author":"S Ouyang","year":"2019","unstructured":"Ouyang S, Zeng Q, Tang N, Guo H, Tang R, Yin W et al (2019) Akt-1 and Akt-2 differentially regulate the development of experimental autoimmune encephalomyelitis by controlling proliferation of thymus-derived regulatory T cells. J Immunol 202(5):1441\u20131452. https:\/\/doi.org\/10.4049\/jimmunol.1701204","journal-title":"J Immunol"},{"key":"6190_CR177","doi-asserted-by":"publisher","unstructured":"Yuk CM, Hong S, Kim D, Kim M, Jeong HW, Park SJ et al (2025) Inositol polyphosphate multikinase regulates Th1 and Th17 cell differentiation by controlling Akt-mTOR signaling. Cell Rep 44(2). https:\/\/doi.org\/10.1016\/j.celrep.2025.115281","DOI":"10.1016\/j.celrep.2025.115281"},{"issue":"18","key":"6190_CR178","doi-asserted-by":"publisher","first-page":"12446","DOI":"10.1074\/jbc.M114.550723","volume":"289","author":"SQ Liu","year":"2014","unstructured":"Liu SQ, Jiang S, Li C, Zhang B, Li QJ (2014) Mir-17-92 cluster targets phosphatase and tensin homology and ikaros family zinc finger 4 to promote th17-mediated inflammation. J Biol Chem 289(18):12446\u201312456. https:\/\/doi.org\/10.1074\/jbc.M114.550723","journal-title":"J Biol Chem"},{"issue":"13","key":"6190_CR179","doi-asserted-by":"publisher","first-page":"4453","DOI":"10.1523\/JNEUROSCI.4311-13.2014","volume":"34","author":"SE Wahl","year":"2014","unstructured":"Wahl SE, McLane LE, Bercury KK, Macklin WB, Wood TL (2014) Mammalian target of rapamycin promotes oligodendrocyte differentiation, initiation and extent of CNS myelination. J Neurosci 34(13):4453. https:\/\/doi.org\/10.1523\/JNEUROSCI.4311-13.2014","journal-title":"J Neurosci"},{"issue":"4","key":"6190_CR180","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1523\/JNEUROSCI.0010-22.2022","volume":"43","author":"KD Dahl","year":"2023","unstructured":"Dahl KD, Almeida AR, Hathaway HA, Bourne J, Brown TL, Finseth LT et al (2023) mTORC2 loss in oligodendrocyte progenitor cells results in regional hypomyelination in the central nervous system. J Neurosci 43(4):540\u2013558. https:\/\/doi.org\/10.1523\/JNEUROSCI.0010-22.2022","journal-title":"J Neurosci"},{"issue":"41","key":"6190_CR181","doi-asserted-by":"publisher","first-page":"8321","DOI":"10.1523\/JNEUROSCI.1377-20.2021","volume":"41","author":"MA Jeffries","year":"2021","unstructured":"Jeffries MA, McLane LE, Khandker L, Mather ML, Evangelou AV, Kantak D et al (2021) mtor signaling regulates metabolic function in oligodendrocyte precursor cells and promotes efficient brain remyelination in the cuprizone model. J Neurosci 41(41):8321\u20138337. https:\/\/doi.org\/10.1523\/JNEUROSCI.1377-20.2021","journal-title":"J Neurosci"},{"issue":"6","key":"6190_CR182","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1111\/j.1471-4159.2006.04329.x","volume":"100","author":"QL Cui","year":"2007","unstructured":"Cui QL, Almazan G (2007) IGF-I-induced oligodendrocyte progenitor proliferation requires PI3K\/Akt, MEK\/ERK, and Src-like tyrosine kinases. J Neurochem 100(6):1480\u20131493. https:\/\/doi.org\/10.1111\/j.1471-4159.2006.04329.x","journal-title":"J Neurochem"},{"key":"6190_CR183","doi-asserted-by":"publisher","unstructured":"Kumar S, Patel R, Moore S, Crawford DK, Suwanna N, Mangiardi M et al (2013) Estrogen receptor \u03b2 ligand therapy activates PI3K\/Akt\/mTOR signaling in oligodendrocytes and promotes remyelination in a mouse model of multiple sclerosis. Neurobiol Dis 56:131\u2013144. https:\/\/doi.org\/10.1016\/j.nbd.2013.04.005","DOI":"10.1016\/j.nbd.2013.04.005"},{"issue":"116","key":"6190_CR184","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.fitote.2016.11.010","volume":"1","author":"S Giacoppo","year":"2017","unstructured":"Giacoppo S, Pollastro F, Grassi G, Bramanti P, Mazzon E (2017) Target regulation of PI3K\/Akt\/mTOR pathway by cannabidiol in treatment of experimental multiple sclerosis. Fitoterapia 1(116):77\u201384. https:\/\/doi.org\/10.1016\/j.fitote.2016.11.010","journal-title":"Fitoterapia"},{"issue":"4","key":"6190_CR185","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.stem.2019.08.015","volume":"25","author":"B Neumann","year":"2019","unstructured":"Neumann B, Baror R, Zhao C, Segel M, Dietmann S, Rawji KS et al (2019) Metformin restores CNS remyelination capacity by rejuvenating aged stem cells. Cell Stem Cell 25(4):473-485.e8. https:\/\/doi.org\/10.1016\/j.stem.2019.08.015","journal-title":"Cell Stem Cell"},{"key":"6190_CR186","doi-asserted-by":"publisher","unstructured":"Narine M, Azmi MA, Umali M, Volz A, Colognato H (2023) The AMPK activator metformin improves recovery from demyelination by shifting oligodendrocyte bioenergetics and accelerating OPC differentiation. Front Cell Neurosci 17. https:\/\/doi.org\/10.3389\/FNCEL.2023.1254303","DOI":"10.3389\/FNCEL.2023.1254303"},{"key":"6190_CR187","doi-asserted-by":"publisher","unstructured":"Rocha SM, Saraiva T, Crist\u00f3v\u00e3o AC, Ferreira R, Santos T, Esteves M et al (2016) Histamine induces microglia activation and dopaminergic neuronal toxicity via H1 receptor activation. J Neuroinflammation 13(1). https:\/\/doi.org\/10.1186\/s12974-016-0600-0","DOI":"10.1186\/s12974-016-0600-0"},{"key":"6190_CR188","unstructured":"Rafiee Zadeh A, Falahatian M, Alsahebfosoul F (2018) Serum levels of histamine and diamine oxidase in multiple sclerosis. Am J Clin Exp Immunol [Internet]. Available from: www.ajcei.us\/ISSN:2164-7712\/AJCEI0086352.\u00a0Accessed 26 Feb 2026"},{"issue":"5","key":"6190_CR189","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.neuint.2005.11.014","volume":"48","author":"QL Cui","year":"2006","unstructured":"Cui QL, Fogle E, Almazan G (2006) Muscarinic acetylcholine receptors mediate oligodendrocyte progenitor survival through Src-like tyrosine kinases and PI3K\/Akt pathways. Neurochem Int 48(5):383\u2013393. https:\/\/doi.org\/10.1016\/j.neuint.2005.11.014","journal-title":"Neurochem Int"},{"key":"6190_CR190","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.jep.2016.12.035","volume":"198","author":"R Venkatesan","year":"2017","unstructured":"Venkatesan R, Shim WS, Yeo EJ, Kim SY (2017) Lactucopicrin potentiates neuritogenesis and neurotrophic effects by regulating Ca2+\/CaMKII\/ATF1 signaling pathway. J Ethnopharmacol 198:174\u2013183. https:\/\/doi.org\/10.1016\/j.jep.2016.12.035","journal-title":"J Ethnopharmacol"},{"issue":"11","key":"6190_CR191","doi-asserted-by":"publisher","first-page":"3943","DOI":"10.1093\/brain\/awac207","volume":"145","author":"C Cordano","year":"2022","unstructured":"Cordano C, Sin JH, Timmons G, Yiu HH, Stebbins K, Guglielmetti C et al (2022) Validating visual evoked potentials as a preclinical, quantitative biomarker for remyelination efficacy. Brain 145(11):3943\u20133952. https:\/\/doi.org\/10.1093\/brain\/awac207","journal-title":"Brain"},{"key":"6190_CR192","unstructured":"Stephen Huhn MD CT. Study to evaluate the safety and efficacy of PIPE-307 in subjects with relapsing-remitting multiple sclerosis [Internet]. [cited 2026 Jan 28]. Available from: \nhttps:\/\/clinicaltrials.gov\/study\/NCT06083753.\u00a0Accessed 26 Feb 2026"},{"issue":"1","key":"6190_CR193","doi-asserted-by":"publisher","first-page":"205521732513269","DOI":"10.1177\/20552173251326913","volume":"11","author":"E Martin","year":"2025","unstructured":"Martin E, Aigrot MS, Fr\u00e8re N, Lepaulmier R, Stankoff B, Boschert U et al (2025) Positive effect of evobrutinib in CNS remyelination models and lack of synergy with clemastine\u2014A dose response study. Mult Scler J Exp Transl Clin 11(1):20552173251326910. https:\/\/doi.org\/10.1177\/20552173251326913","journal-title":"Mult Scler J Exp Transl Clin"},{"key":"6190_CR194","doi-asserted-by":"publisher","unstructured":"Li Y, Li P, Song Y, Zhang W, Jiang X, Chen S et al (2025) Combination therapy dramatically promotes remyelination. J Mol Cell Biol 17(3). https:\/\/doi.org\/10.1093\/jmcb\/mjaf005","DOI":"10.1093\/jmcb\/mjaf005"},{"issue":"253","key":"6190_CR195","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/J.NEUROSCIENCE.2013.08.051","volume":"3","author":"H Li","year":"2013","unstructured":"Li H, Park D, Muneer PMA, Xu B, Wang H, Xing B et al (2013) PI3K\u03b3 inhibition alleviates symptoms and increases axon number in experimental autoimmune encephalomyelitis mice. Neuroscience 3(253):89. https:\/\/doi.org\/10.1016\/J.NEUROSCIENCE.2013.08.051","journal-title":"Neuroscience"},{"key":"6190_CR196","unstructured":"Shang SQ, Li J, Li SQ, Cao YL (2015) Inhibition of phosphoinositide 3-kinase delta attenuates experimental autoimmune encephalomyelitis in mice. Int J Clin Exp Med [Internet]. Available from: www.ijcem.com\/.\u00a0Accessed 26 Feb 2026"},{"key":"6190_CR197","doi-asserted-by":"publisher","unstructured":"Jung JS, Choi MJ, Lee YY, Moon BI, Park JS, Kim HS (2017) Suppression of Lipopolysaccharide-induced neuroinflammation by Morin via MAPK, PI3K\/Akt, and PKA\/HO-1 signaling pathway modulation. J Agric Food Chem 65(2):373\u2013382. https:\/\/doi.org\/10.1021\/ACS.JAFC.6B05147","DOI":"10.1021\/ACS.JAFC.6B05147"},{"issue":"111","key":"6190_CR198","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.molimm.2019.03.015","volume":"1","author":"H Datler","year":"2019","unstructured":"Datler H, Vogel A, Kerndl M, Baumgartinger C, Musiejovsky L, Makivic N et al (2019) PI3K activity in dendritic cells exerts paradoxical effects during autoimmune inflammation. Mol Immunol 1(111):32\u201342. https:\/\/doi.org\/10.1016\/j.molimm.2019.03.015","journal-title":"Mol Immunol"},{"issue":"4","key":"6190_CR199","doi-asserted-by":"publisher","first-page":"9322","DOI":"10.1080\/21655979.2022.2052671","volume":"13","author":"K Zheng","year":"2022","unstructured":"Zheng K, Lv B, Wu L, Wang C, Xu H, Li X et al (2022) Protecting effect of emodin in experimental autoimmune encephalomyelitis mice by inhibiting microglia activation and inflammation via Myd88\/PI3K\/Akt\/NF-\u03baB signalling pathway. Bioengineered 13(4):9322\u20139344. https:\/\/doi.org\/10.1080\/21655979.2022.2052671","journal-title":"Bioengineered"},{"key":"6190_CR200","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.ejphar.2024.176929","volume":"5","author":"MS Shafiek","year":"2024","unstructured":"Shafiek MS, Mekky RY, Nassar NN, El-Yamany MF, Rabie MA (2024) Vortioxetine ameliorates experimental autoimmune encephalomyelitis model of multiple sclerosis in mice via activation of PI3K\/Akt\/CREB\/BDNF cascade and modulation of serotonergic pathway signaling. Eur J Pharmacol 5:982. https:\/\/doi.org\/10.1016\/j.ejphar.2024.176929","journal-title":"Eur J Pharmacol"},{"issue":"5","key":"6190_CR201","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.1172\/JCI73411","volume":"124","author":"T Koga","year":"2014","unstructured":"Koga T, Hedrich CM, Mizui M, Yoshida N, Otomo K, Lieberman LA et al (2014) CaMK4-dependent activation of AKT\/mTOR and CREM-\u03b1 underlies autoimmunity-associated Th17 imbalance. J Clin Investig 124(5):2234\u20132245. https:\/\/doi.org\/10.1172\/JCI73411","journal-title":"J Clin Investig"},{"key":"6190_CR202","doi-asserted-by":"publisher","unstructured":"Liu Q, Qiu J, Liang M, Golinski J, Van Leyen K, Jung JE et al (2014) Akt and mTOR mediate programmed necrosis in neurons. Cell Death Dis 5(2). https:\/\/doi.org\/10.1038\/cddis.2014.69","DOI":"10.1038\/cddis.2014.69"},{"issue":"30","key":"6190_CR203","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.intimp.2015.11.024","volume":"1","author":"H Hou","year":"2016","unstructured":"Hou H, Cao R, Miao J, Sun Y, Liu X, Song X et al (2016) Fingolimod ameliorates the development of experimental autoimmune encephalomyelitis by inhibiting Akt-mTOR axis in mice. Int Immunopharmacol 1(30):171\u2013178. https:\/\/doi.org\/10.1016\/j.intimp.2015.11.024","journal-title":"Int Immunopharmacol"},{"key":"6190_CR204","unstructured":"Feng X, Yu S, Hou H, Zou Y, Chen J, Guo L (2018) Rapamycin reduces degeneration of neurons by inhibiting Akt\/mTOR\/p70S6K pathway and restoring autophagy in EAE mice. Int J Clin Exp Med [Internet]. Available from: www.ijcem.com\/.\u00a0Accessed 26 Feb 2026"},{"issue":"324","key":"6190_CR205","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jneuroim.2018.08.012","volume":"15","author":"H Hou","year":"2018","unstructured":"Hou H, Cao R, Quan M, Sun Y, Sun H, Zhang J et al (2018) Rapamycin and fingolimod modulate Treg\/Th17 cells in experimental autoimmune encephalomyelitis by regulating the Akt-mTOR and MAPK\/ERK pathways. J Neuroimmunol 15(324):26\u201334. https:\/\/doi.org\/10.1016\/j.jneuroim.2018.08.012","journal-title":"J Neuroimmunol"},{"issue":"41","key":"6190_CR206","doi-asserted-by":"publisher","first-page":"8532","DOI":"10.1523\/JNEUROSCI.0783-21.2021","volume":"41","author":"KN Fedder-Semmes","year":"2021","unstructured":"Fedder-Semmes KN, Appel B (2021) The Akt-mTOR pathway drives myelin sheath growth by regulating cap-dependent translation. J Neurosci 41(41):8532\u201344. https:\/\/doi.org\/10.1523\/JNEUROSCI.0783-21.2021","journal-title":"J Neurosci"},{"issue":"6","key":"6190_CR207","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1007\/s13760-020-01518-9","volume":"121","author":"FB Oktelik","year":"2021","unstructured":"Oktelik FB, Yilmaz V, Turkoglu R, Akbayir E, Tuzun E, Deniz G et al (2021) Expression of Akt1 and p-Akt1 in peripheral T cell subsets of multiple sclerosis patients. Acta Neurol Belg 121(6):1777\u201382. https:\/\/doi.org\/10.1007\/s13760-020-01518-9","journal-title":"Acta Neurol Belg"},{"issue":"7","key":"6190_CR208","doi-asserted-by":"publisher","first-page":"4166","DOI":"10.1007\/s12035-023-03833-7","volume":"61","author":"F Huang","year":"2024","unstructured":"Huang F, Mao F, Nong W, Gong Z, Lao D, Huang W (2024) Inhibiting caveolin-1-related Akt\/mTOR signaling pathway protects against N-methyl-D-aspartate receptor activation-mediated dysfunction of blood\u2013brain barrier in vitro. Mol Neurobiol 61(7):4166\u201377. https:\/\/doi.org\/10.1007\/s12035-023-03833-7","journal-title":"Mol Neurobiol"},{"key":"6190_CR209","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/J.BRAINRESBULL.2025.111610","volume":"1","author":"Q Zhang","year":"2025","unstructured":"Zhang Q, Zhang Y, Chen Y, Liu X, Li J, Liu F et al (2025) PD-1\/PD-L1 inhibits M1 polarization of microglia and macrophages through STAT1\/NF-\u03baB and Akt\/mTOR signaling pathways. Brain Res Bull 1:232. https:\/\/doi.org\/10.1016\/J.BRAINRESBULL.2025.111610","journal-title":"Brain Res Bull"},{"key":"6190_CR210","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.neuroscience.2019.01.038","volume":"406","author":"H Yamate-Morgan","year":"2019","unstructured":"Yamate-Morgan H, Lauderdale K, Horeczko J, Merchant U, Tiwari-Woodruff SK (2019) Functional effects of cuprizone-induced demyelination in the presence of the mTOR-inhibitor rapamycin. Neuroscience 406:667\u201383. https:\/\/doi.org\/10.1016\/j.neuroscience.2019.01.038","journal-title":"Neuroscience"},{"issue":"8","key":"6190_CR211","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1007\/s11011-020-00590-7","volume":"35","author":"F Akbarian","year":"2020","unstructured":"Akbarian F, Tabatabaiefar MA, Shaygannejad V, Shahpouri MM, Badihian N, Sajjadi R et al (2020) Upregulation of MTOR, RPS6KB1, and EIF4EBP1 in the whole blood samples of Iranian patients with multiple sclerosis compared to healthy controls. Metab Brain Dis 35(8):1309\u20131316. https:\/\/doi.org\/10.1007\/s11011-020-00590-7","journal-title":"Metab Brain Dis"},{"key":"6190_CR212","doi-asserted-by":"publisher","unstructured":"Sanadgol N, Barati M, Houshmand F, Hassani S, Clarner T, shahlaei M et al (2020) Metformin accelerates myelin recovery and ameliorates behavioral deficits in the animal model of multiple sclerosis via adjustment of AMPK\/Nrf2\/mTOR signaling and maintenance of endogenous oligodendrogenesis during brain self-repairing period. Pharmacol Rep 72(3):641\u201358. https:\/\/doi.org\/10.1007\/s43440-019-00019-8","DOI":"10.1007\/s43440-019-00019-8"},{"key":"6190_CR213","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.bbrc.2021.08.010","volume":"573","author":"M He","year":"2021","unstructured":"He M, Wu DM, Zhao YY, Yu Y, Deng SH, Liu T et al (2021) AZD8055 ameliorates experimental autoimmune encephalomyelitis via the mTOR\/ROS\/NLRP3 pathway. Biochem Biophys Res Commun 573:27\u201334. https:\/\/doi.org\/10.1016\/j.bbrc.2021.08.010","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"6190_CR214","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1007\/s11011-022-01010-8","volume":"37","author":"M Akbari","year":"2022","unstructured":"Akbari M, Eshghyar F, Gholipour M, Eslami S, Hussen BM, Taheri M et al (2022) Expression analysis of mTOR-associated lncRNAs in multiple sclerosis. Metab Brain Dis 37(6):2061\u20132066. https:\/\/doi.org\/10.1007\/s11011-022-01010-8","journal-title":"Metab Brain Dis"},{"issue":"9","key":"6190_CR215","doi-asserted-by":"publisher","first-page":"8263","DOI":"10.18632\/ONCOTARGET.23862","volume":"9","author":"S Mammana","year":"2018","unstructured":"Mammana S, Bramanti P, Mazzon E, Cavalli E, Basile MS, Fagone P et al (2018) Preclinical evaluation of the PI3K\/Akt\/mTOR pathway in animal models of multiple sclerosis. Oncotarget 9(9):8263. https:\/\/doi.org\/10.18632\/ONCOTARGET.23862","journal-title":"Oncotarget"},{"issue":"3","key":"6190_CR216","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/s40120-023-00455-y","volume":"12","author":"YC Zhang","year":"2023","unstructured":"Zhang YC, Fan KY, Wang Q, Hu JX, Wang Q, Zhang HY et al (2023) Genetically determined levels of mTOR-dependent circulating proteins and risk of multiple sclerosis. Neurol Ther 12(3):751\u2013762. https:\/\/doi.org\/10.1007\/s40120-023-00455-y","journal-title":"Neurol Ther"},{"key":"6190_CR217","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.lfs.2017.05.010","volume":"180","author":"SQ Liu","year":"2017","unstructured":"Liu SQ, Zhang ML, Zhang HuJ, Liu FZ, Chu RJ, Zhang GX et al (2017) Matrine promotes oligodendrocyte development in CNS autoimmunity through the PI3K\/Akt signaling pathway. Life Sci 180:36\u201341. https:\/\/doi.org\/10.1016\/j.lfs.2017.05.010","journal-title":"Life Sci"},{"issue":"1","key":"6190_CR218","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1515\/CHEM-2019-0015\/XML","volume":"17","author":"HQ Liu","year":"2019","unstructured":"Liu HQ, An YW, Hu AZ, Li MH, Wu JL, Liu L et al (2019Jan 1) Critical roles of the PI3K-Akt-mTOR signaling pathway in apoptosis and autophagy of astrocytes induced by methamphetamine. Open Chem 17(1):96\u2013104. https:\/\/doi.org\/10.1515\/CHEM-2019-0015\/XML","journal-title":"Open Chem"},{"key":"6190_CR219","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2019.104630","author":"L Wang","year":"2020","unstructured":"Wang L, Yang H, Zang C, Dong Y, Shang J, Chen J et al (2020) CXCR2 antagonism promotes oligodendrocyte precursor cell differentiation and enhances remyelination in a mouse model of multiple sclerosis. Neurobiol Dis. https:\/\/doi.org\/10.1016\/j.nbd.2019.104630","journal-title":"Neurobiol Dis"},{"issue":"24","key":"6190_CR220","doi-asserted-by":"publisher","first-page":"25931","DOI":"10.18632\/AGING.203781","volume":"13","author":"J Wang","year":"2021","unstructured":"Wang J, Song X, Tan G, Sun P, Guo L, Zhang N et al (2021) NAD+ improved experimental autoimmune encephalomyelitis by regulating SIRT1 to inhibit PI3K\/Akt\/mTOR signaling pathway. Aging 13(24):25931\u201325943. https:\/\/doi.org\/10.18632\/AGING.203781","journal-title":"Aging"},{"key":"6190_CR221","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3389\/fnagi.2022.1075161","volume":"1","author":"W Sun","year":"2022","unstructured":"Sun W, Wen M, Liu M, Wang Q, Liu Q, Li L et al (2022Dec) Effect of \u03b2-hydroxybutyrate on behavioral alterations, molecular and morphological changes in CNS of multiple sclerosis mouse model. Front Aging Neurosci 1:14. https:\/\/doi.org\/10.3389\/fnagi.2022.1075161","journal-title":"Front Aging Neurosci"},{"issue":"159","key":"6190_CR222","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.molimm.2023.05.005","volume":"1","author":"M Sun","year":"2023","unstructured":"Sun M, Gong P, Yuan B, Liu N, Li X, Zhang W et al (2023) AXL-Induced Autophagy mitigates experimental autoimmune encephalomyelitis by suppressing microglial inflammation via the PI3K\/AKT\/mTOR signaling pathway. Mol Immunol 1(159):15\u201327. https:\/\/doi.org\/10.1016\/j.molimm.2023.05.005","journal-title":"Mol Immunol"},{"key":"6190_CR223","doi-asserted-by":"publisher","unstructured":"Shi XY, He YX, Ge MY, Liu P, Zheng P, Li ZH (2025) Gastrodin promotes CNS myelinogenesis and alleviates demyelinating injury by activating the PI3K\/AKT\/mTOR signaling. Acta Pharmacol Sin 46(6):1610\u20131623. https:\/\/doi.org\/10.1038\/s41401-025-01492-z","DOI":"10.1038\/s41401-025-01492-z"},{"key":"6190_CR224","doi-asserted-by":"publisher","unstructured":"Wu N, Zhao Y, Xiao M, Liu H, Chen H, Liu B et al (2025) Methylprednisolone modulates the Tfr\/Tfh ratio in EAE-induced neuroinflammation through the PI3K\/AKT\/FoxO1 and PI3K\/AKT\/mTOR signalling pathways. Inflammation 48(2):950\u2013962. https:\/\/doi.org\/10.1007\/S10753-024-02099-Y","DOI":"10.1007\/S10753-024-02099-Y"},{"issue":"4","key":"6190_CR225","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.celrep.2012.02.007","volume":"1","author":"Y Kurebayashi","year":"2012","unstructured":"Kurebayashi Y, Nagai S, Ikejiri A, Ohtani M, Ichiyama K, Baba Y et al (2012) PI3K-Akt-mTORC1-S6K1\/2 axis controls Th17 differentiation by regulating Gfi1 expression and nuclear translocation of ROR\u03b3. Cell Rep 1(4):360\u2013373. https:\/\/doi.org\/10.1016\/j.celrep.2012.02.007","journal-title":"Cell Rep"},{"issue":"4","key":"6190_CR226","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/NI.2005","volume":"12","author":"GM Delgoffe","year":"2011","unstructured":"Delgoffe GM, Pollizzi KN, Waickman AT, Heikamp E, Meyers DJ, Horton MR et al (2011) The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2. Nat Immunol 12(4):295\u2013304. https:\/\/doi.org\/10.1038\/NI.2005","journal-title":"Nat Immunol"},{"issue":"12","key":"6190_CR227","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1002\/glia.22729","volume":"62","author":"J Dai","year":"2014","unstructured":"Dai J, Bercury KK, Macklin WB (2014) Interaction of mTOR and Erk1\/2 signaling to regulate oligodendrocyte differentiation. Glia 62(12):2096\u20132109. https:\/\/doi.org\/10.1002\/glia.22729","journal-title":"Glia"},{"issue":"5","key":"6190_CR228","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1111\/j.1471-4159.2009.06071.x","volume":"109","author":"O Bibollet-Bahena","year":"2009","unstructured":"Bibollet-Bahena O, Almazan G (2009) IGF-1-stimulated protein synthesis in oligodendrocyte progenitors requires PI3K\/mTOR\/Akt and MEK\/ERK pathways. J Neurochem 109(5):1440\u20131451. https:\/\/doi.org\/10.1111\/j.1471-4159.2009.06071.x","journal-title":"J Neurochem"},{"issue":"2","key":"6190_CR229","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/S12035-014-8678-9","volume":"50","author":"L Zhou","year":"2014","unstructured":"Zhou L, Shao CY, Xu S, Ma J, Xie YJ, Zhou L et al (2014) GSK3\u03b2 promotes the differentiation of oligodendrocyte precursor cells via \u03b2-catenin-mediated transcriptional regulation. Mol Neurobiol 50(2):507\u2013519. https:\/\/doi.org\/10.1007\/S12035-014-8678-9","journal-title":"Mol Neurobiol"},{"issue":"25","key":"6190_CR230","doi-asserted-by":"publisher","first-page":"8467","DOI":"10.1523\/JNEUROSCI.0311-14.2014","volume":"34","author":"ZM Dai","year":"2014","unstructured":"Dai ZM, Sun S, Wang C, Huang H, Hu X, Zhang Z et al (2014) Stage-specific regulation of oligodendrocyte development by Wnt\/\u03b2-catenin signaling. J Neurosci 34(25):8467\u20138473. https:\/\/doi.org\/10.1523\/JNEUROSCI.0311-14.2014","journal-title":"J Neurosci"},{"key":"6190_CR231","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2021.101330","author":"DS Prado","year":"2021","unstructured":"Prado DS, Cattley RT, Shipman CW, Happe C, Lee M, Boggess WC et al (2021) Synergistic and additive interactions between receptor signaling networks drive the regulatory T cell versus T helper 17 cell fate choice. J Biol Chem. https:\/\/doi.org\/10.1016\/j.jbc.2021.101330","journal-title":"J Biol Chem"},{"issue":"6","key":"6190_CR232","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1007\/S12640-021-00417-Y","volume":"39","author":"M Abdi","year":"2021","unstructured":"Abdi M, Pasbakhsh P, Shabani M, Nekoonam S, Sadeghi A, Fathi F et al (2021) Metformin therapy attenuates pro-inflammatory microglia by inhibiting NF-\u03baB in cuprizone demyelinating mouse model of multiple sclerosis. Neurotox Res 39(6):1732\u20131746. https:\/\/doi.org\/10.1007\/S12640-021-00417-Y","journal-title":"Neurotox Res"},{"issue":"2","key":"6190_CR233","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/S40199-019-00286-Z","volume":"27","author":"F Houshmand","year":"2019","unstructured":"Houshmand F, Barati M, Golab F, Ramezani-sefidar S, Tanbakooie S, Tabatabaei M et al (2019) Metformin-induced AMPK activation stimulates remyelination through induction of neurotrophic factors, downregulation of NogoA and recruitment of Olig2+ precursor cells in the cuprizone murine model of multiple sclerosis. Daru 27(2):583\u2013592. https:\/\/doi.org\/10.1007\/S40199-019-00286-Z","journal-title":"Daru"},{"key":"6190_CR234","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2016.03.008","author":"JM Gaesser","year":"2016","unstructured":"Gaesser JM, Fyffe-Maricich SL (2016) Intracellular signaling pathway regulation of myelination and remyelination in the CNS. Exp Neurol. https:\/\/doi.org\/10.1016\/j.expneurol.2016.03.008","journal-title":"Exp Neurol"},{"key":"6190_CR235","doi-asserted-by":"publisher","unstructured":"Koks F, Reubens F, van der Zee H, Bried\u00e9 JJ (2026) The dual role of mTOR in multiple sclerosis pathophysiology: a systematic review. J Neurol 273(8). https:\/\/doi.org\/10.1007\/S00415-026-13970-3","DOI":"10.1007\/S00415-026-13970-3"},{"key":"6190_CR236","doi-asserted-by":"publisher","DOI":"10.3389\/fnsys.2012.00032","author":"MB Passani","year":"2012","unstructured":"Passani MB, Ballerini C (2012) Histamine and neuroinflammation: Insights from murine experimental autoimmune encephalomyelitis. Front Syst Neurosci. https:\/\/doi.org\/10.3389\/fnsys.2012.00032","journal-title":"Front Syst Neurosci"},{"issue":"25","key":"6190_CR237","doi-asserted-by":"publisher","first-page":"8432","DOI":"10.1523\/JNEUROSCI.1105-14.2014","volume":"34","author":"F Lebrun-Julien","year":"2014","unstructured":"Lebrun-Julien F, Bachmann L, Norrm\u00e9n C, Tr\u00f6tzm\u00fcller M, K\u00f6feler H, R\u00fcegg MA et al (2014) Balanced mTORC1 activity in oligodendrocytes is required for accurate CNS myelination. J Neurosci 34(25):8432\u20138448. https:\/\/doi.org\/10.1523\/JNEUROSCI.1105-14.2014","journal-title":"J Neurosci"},{"key":"6190_CR238","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2026.117538","author":"AMR van den Bosch","year":"2026","unstructured":"van den Bosch AMR, Khoo JH, Lu Z, Liang H, Wever D, Pu L et al (2026) Microglial states associate with lesion dynamics in multiple sclerosis. Cell Rep. https:\/\/doi.org\/10.1016\/j.celrep.2026.117538","journal-title":"Cell Rep"},{"key":"6190_CR239","doi-asserted-by":"publisher","unstructured":"Caverzasi E, Papinutto N, Cordano C, Kirkish G, Gundel TJ, Zhu A et al (2023) MWF of the corpus callosum is a robust measure of remyelination: Results from the ReBUILD trial. Proc Natl Acad Sci USA 120(20). https:\/\/doi.org\/10.1073\/PNAS.2217635120","DOI":"10.1073\/PNAS.2217635120"},{"key":"6190_CR240","doi-asserted-by":"publisher","unstructured":"Riboni-Verri G, McMurran CE, Mukherjee T, Daruwalla C, Holland J, Gautam R, Chen BS, Cutting E, Qian W, MacManus D, Chard DT, Brown JWL, Coles AJ, Cunniffe NG (2025) The Cambridge Centre for Myelin Repair trial Two (CCMR Two): a trial protocol for a phase 2a, randomised, double-blind, placebo-controlled clinical trial of the ability of the combination of metformin and clemastine to promote remyelination in people with relapsing-remitting multiple sclerosis already on disease-modifying therapy. Trials 26(1):562. https:\/\/doi.org\/10.1186\/s13063-025-09254-2","DOI":"10.1186\/s13063-025-09254-2"},{"issue":"35","key":"6190_CR241","doi-asserted-by":"publisher","first-page":"9253","DOI":"10.1523\/JNEUROSCI.4587-15.2016","volume":"36","author":"M Zhao","year":"2016","unstructured":"Zhao M, Sun D, Guan Y, Wang Z, Sang D, Liu M et al (2016) Disulfiram and diphenhydramine hydrochloride upregulate miR-30a to suppress IL-17-associated autoimmune inflammation. J Neurosci 36(35):9253\u20139266. https:\/\/doi.org\/10.1523\/JNEUROSCI.4587-15.2016","journal-title":"J Neurosci"},{"issue":"11","key":"6190_CR242","doi-asserted-by":"publisher","DOI":"10.3390\/CELLS15111012","volume":"15","author":"ME Kim","year":"2026","unstructured":"Kim ME, Lee JS (2026) Pharmacological targeting of PI3K\/Akt\/mTOR and Wnt\/GSK-3\u03b2 signaling in oligodendrocyte differentiation and remyelination. Cells 15(11):1012. https:\/\/doi.org\/10.3390\/CELLS15111012","journal-title":"Cells"},{"issue":"19","key":"6190_CR243","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1056\/NEJMOA2415988","volume":"392","author":"RJ Fox","year":"2025","unstructured":"Fox RJ, Bar-Or A, Traboulsee A, Oreja-Guevara C, Giovannoni G, Vermersch P et al (2025) Tolebrutinib in nonrelapsing secondary progressive multiple sclerosis. N Engl J Med 392(19):1883\u20131892. https:\/\/doi.org\/10.1056\/NEJMOA2415988","journal-title":"N Engl J Med"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-06190-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-026-06190-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-06190-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T14:36:15Z","timestamp":1788964575000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-026-06190-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":243,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["6190"],"URL":"https:\/\/doi.org\/10.1007\/s12035-026-06190-3","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"6 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Authors approve for submitting the publication.","order":2,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"886"}}